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CV 
In 2009, I graduated in Medicine and Surgery with a grade of 110/110 “cum laude” 
at the University of Siena (Italy), obtaining the qualification of Medical Doctor. 
From 2010 to 2015, I enrolled at the School of Specialization in Sport and Exercise 
Medicine, University of Florence, obtaining the qualification of Sports Physician. 
Since the beginning of my clinical training, I focused my learning on the assessment 
and the treatment of the disorders of the musculoskeletal system, on the use of the 
musculoskeletal ultrasound imaging and the ultrasound-guided interventions. In 
2013, these skills produced an intensive collaboration with Italian Swimming 
Federation aimed at developing the application of rehabilitative ultrasound imaging 
in sport rehabilitation and injury prevention in elite athletes. From 2014, I worked as 
an occupational trainee at the Center of Clinical Research Excellence in Spine Pain, 
University of Queensland (Australia), where I have trained to use intramuscular 
electromyography of the trunk muscles and kinematic evaluation of the trunk 
movement. In October 2015, I have been enrolled as a PhD fellow in CNAP, 
Aalborg University (Denmark). My research project aimed at probing the nature and 
the time-course of cortical neuroplastic changes provoked by muscle pain across 
several days and at modulating the cortical pain neuroplasticity by repetitive 
transcranial magnetic stimulation. In parallel with my PhD project, I have 
contributed in developing two researches projects: Parabolic flight (Inter-Agency 
Partial Gravity Campaign, Bordeaux, 2018) and Bed-rest study (joint ESA/NASA 
Artificial Gravity Study, Cologne, 2019), in collaboration with European Space 
Agency (Space Medicine Office) and Northumbria University (Aerospace Medicine 
and Rehabilitation Laboratory). These projects aimed at developing 
countermeasures to maintain the human spine in healthy conditions during long 
space missions and on Lunar and Martial surfaces. 
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ENGLISH SUMMARY 
Chronic musculoskeletal pain is one of the main causes of living with disability. 
Yet, one of the major problems in planning new therapeutic strategies is that the 
mechanisms causing pain are not completely clear. Recent pain researches have 
highlighted the role of nervous system in maintaining pain chronicity due to 
maladaptive neuroplasticity. However, it is still unclear how neuroplasticity is 
modified during the transition from acute to chronic pain and when neuroplastic 
changes appear. Therefore, the first aim of the present Ph.D. project was to 
investigate the nature and time-course of cortical neuroplasticity provoked by long-
lasting muscle pain. In addition, interventions able to reverse pain neuroplasticity 
have been recently proposed to treat musculoskeletal pain. Consequently, the second 
aim of this project was to modulate the cortical excitability changes provoked by 
long-lasting muscle pain applying consecutive daily sessions of repetitive 
transcranial magnetic stimulation (rTMS) to the left dorsolateral prefrontal cortex 
(DLPFC). 
To provoke long-lasting muscle pain, three pain models were used in healthy 
subjects: eccentric exercise-induced delayed-onset muscle soreness (DOMS) (Study 
I), muscle pain induced by repeated intramuscular injections of nerve growth factor 
(NGF) (Study II and III) and a combination of muscle pain provoked by NGF and 
eccentric exercise-induced DOMS (Study II). 
To probe the nature and time-course of cortical excitability changes, motor evoked 
potentials induced by transcranial magnetic stimulation and somatosensory evoked 
potentials induced by electrical stimulation of a nerve were collected before and 
during the application of the three pain models (Study I, study II and III). These two 
neurophysiological measurements were selected because they are generated in 
specific sensorimotor cortical regions and their changes have been previously 
interpreted as sign of neuroplasticity. 
Finally, to modulate pain neuroplasticity, daily sessions of 10Hz rTMS were applied 
to the left DLPFC during long-lasting muscle pain provoked by intramuscular 
injections of NGF (Study III). The left DLPFC was selected because this cortical 
region has been suggested to play a key role in pain perception and pain 
suppression.  
The results of the first and second study suggested that muscle pain induced by 
DOMS, intramuscular injections NGF and the two models combined are able to 
provoke long-lasting muscle pain up to 20 days, muscle hyperalgesia and functional 
disability. Moreover, temporary cortical excitability changes were probed: While 
DOMS inhibited the corticomotor excitability, intramuscular injections of NGF 
facilitated it. Additionally, intramuscular injections of NGF impaired both frontal 
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and centro-parietal sensory cortical excitability while DOMS impaired only centro-
parietal sensory cortical excitability. In conclusion, these findings suggest that 
eccentric exercise-induced DOMS and muscle pain induced by NGF provoked 
different cortical sensorimotor adaptations. 
The results from the third study showed that consecutive daily sessions of 10Hz 
rTMS to the left DLPFC modulated the corticomotor and sensory cortical 
adaptations during muscle pain provoked by intramuscular injections NGF, as well 
as reduced hyperalgesia, pain intensity and functional disability.  
In conclusion, the results of this Ph. D. project showed promising findings regarding 
the opportunity to provoke and to modulate pain-induced cortical neuroplasticity 
across several days as well as analgesic effects of daily sessions of 10 Hz left 
DLPFC rTMS.   
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DANSK RESUME 
Kronisk muskuloskeletal smerte er den største årsag til funktionsnedsættelse på 
verdensplan. Alligevel er et af de største problemer i udviklingen af nye 
behandlingsstrategier, at de underliggende mekanismer bag muskuloskeletal smerte 
ikke er helt forstået. Ny smerteforskning har fremhævet centralnervesystemet og 
dets rolle i opretholdelsen af kronisk smerte grundet maladaptiv neuroplasticitet. Det 
er dog stadig uvist, hvordan neuroplasticitet ændres under udviklingen fra akut til 
kronisk smerte og på hvilke tidspunkter disse ændring finder sted. Derfor var det 
første mål for dette ph.d.-projekt at undersøge karakteristika samt tidsforløbet af 
kortikale neuroplasticitetsændringer i forbindelse med længerevarende 
muskelsmerter. Derudover er nye interventioner, der kan ændre 
smerteneuroplasticitet, for nyligt blevet anbefalet til behandling af muskuloskeletale 
smerter. Derfor var det andet formål med dette projekt at modulere de kortikale 
ændringer som langvarig muskelsmerte fremkalder, ved flere sessioner af repetitiv 
transkraniel magnetisk stimulation (rTMS) på venstre dorsolaterale præfrontale 
kortex (DLPFC). 
For at provokere langvarig muskelsmerte blev tre smertemodeller anvendt i raske 
forsøgspersoner: 1) Excentrisk træning blev brugt til udviklingen af forsinket 
muskelømhed (delayed-onset muscle soreness, DOMS) (Studie I), 2) muskelsmerter 
induceret ved gentagende intramuskulære injektioner af nerve growth factor (NGF) 
(Studie II), og 3) muskelsmerter induceret via en kombination af gentagende 
intramuskulære injektioner af NGF og excentrisk træning (DOMS) (Studie III). 
For at undersøge karakteristika og tidsforløbet af de kortikale excitabilitetsændringer 
blev motor-evokerede potentialer (MEPer), induceret af transkraniel magnetisk 
stimuletion (TMS), og somatosensorisk evokerede potentialer (SEPer), fremkaldt af 
elektrisk nervestimulering, indsamlet før og efter anvendelse af de tre 
smertemodeller (Studie I, II og III). Disse to neurofysiologiske målinger blev valgt 
da de genereres i de sensomotoriske kortikale regioner, og deres ændringer er 
tidligere blevet fortolket som tegn på neuroplasticitet. 
Til modulering af smerteneuroplasticitet, blev flere sessioner af rTMS af det venstre 
DLPFC anvendt under langvarig muskelsmerte induceret af intramuskulære 
injektioner af NGF (Studie III). Det venstre DLPFC blev valgt, da det har vist sig at 
spille en vigtig rolle i smerteopfattelse samt smertereduktion. 
Resultaterne fra det første og andet studie viste, at muskelsmerter induceret af 
DOMS, intramuskulære injektioner af NGF, og en kombination af de to, er i stand til 
at fremkalde langvarig muskelsmerte i op til 20 dage, muskelhyperalgesi og 
funktionsnedsættelse. Endvidere blev de kortikale excitabilitetsændringer undersøgt: 
Mens DOMS hæmmede den kortikale motoriske excitabilitet, blev den øget af 
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intramuskulære injektioner af NGF. Derudover hæmmede intramuskulære 
injektioner af NGF både den frontale og centro-parietale kortikale sensoriske 
excitabilitet, mens DOMS kun hæmmede den centro-parietale kortikale sensoriske 
excitabilitet. Sammenfattende tyder disse resultater på, at DOMS og muskelsmerter, 
induceret af NGF, provokerede forskellige kortikale sensomotoriske ændringer. 
Resultaterne fra det tredje studie viste, at flere sessioner af rTMS af det venstre 
DLPFC var i stand til at modulere kortikale motoriske og sensoriske ændringer 
under muskelsmerte, induceret af intramuskulær injektioner af NGF, såvel som 
reduceret hyperalgesi, smerteintensitet og graden af funktionsnedsættelse. 
Afslutningsvis viste resultaterne af dette ph.d.-projekt for første gang lovende 
resultater vedrørende muligheden for at provokere og modulere smerteinduceret 
kortikal neuroplasticitet over flere dage sammen med en smertelindrende effekt af 
rTMS stimulering af det venstre DLPFC. 
9 
ACKNOWLEDGEMENTS 
First, I would like to thank my supervisor, Prof. Thomas Graven-Nielsen, for giving 
me with the opportunity to continue my professional development with his research 
group (CNAP). Thomas did not only demonstrate a very friendly and helpful 
character, always available to provide support and important comments, but he has 
been a good example of a group leader.    
I would like to thank the co-authors of this project: Dr. Siobhan Schabrun, Dr. David 
Seminowicz, Prof. Laura Petrini and Dr. Matteo Zandalasini, for their valuable 
contribution to develop the aims of this project and to improve the quality of my 
papers.  
A special thank goes to Prof. Daniel Ciampi de Andrade and to his research group 
for their kindness and help during my research external project. 
I want to acknowledge all of my colleagues in CNAP, SMI and the staff of Aalborg 
University for their contribution. My special appreciation goes to Dennis Boye 
Larsen, Silvia Lo Vecchio and Ning Qu. Dennis has been a great help on developing 
the experimental setup and the analysis and, Silva and Ning have been great friends 
during these years in Aalborg.  
I would like to also express all my gratitude to my previous supervisors: Prof. Marco 
Bonifazi, Prof. François Hug, Dr. Kylie Tucker and Prof. Paul Hodges for their help 
in developing my clinical and research career.  
Finally, I am deeply thankful for my girlfriend, Yin Ka Lam, my friends and my 
family. During these years, they encouraged all my decisions and they were always 
cheering me up and stood by me despite the long distances.  
CORTICAL NEUROPLASTICITY PROVOKED BY MUSCLE PAIN AND NON-INVASIVE CORTICAL MODULATION OF 
PAIN-INDUCED NEUROPLASTICITY 
10 
 
PREFACE 
This PhD thesis summarizes the research work realized from November 2015 to 
September 2018 at the Center of Neuroplasticity and Pain (CNAP), Aalborg 
University (Denmark). A stay abroad was carried out at the Pain Center from the 
Hospital das Clínicas, University of São Paulo (Brazil), as part of external 
collaboration with CNAP.  
This project was fully funded by the Danish National Research Foundation.   
The present research project aims at reversing pain neuroplasticity induced by 
muscle pain developing over days (long-lasting muscle pain model) in heathy 
subjects. In order to obtain this goal, three steps were necessary: i) to provoke long-
lasting muscle pain; ii) to probe changes in corticomotor excitability and sensory 
cortical excitability induced by long-lasting muscle pain; iii) to test the modulatory 
effects of consecutive daily sessions of repetitive transcranial magnetic stimulation 
(rTMS) to left dorsolateral prefrontal cortex (DLPFC) during long-lasting muscle 
pain.  
This thesis is divided in 5 chapters. The first chapter presents a brief introduction on 
provoking, probing, and modulating pain neuroplasticity. The second chapter 
defines the experimental pain models used to provoke long-lasting muscle pain and 
the time-course of pain manifestations. The third chapter illustrates the 
neurophysiological tools used to probe cortical neuroplasticity during long-lasting 
muscle pain. The fourth chapter describes the analgesic and neuromodulatory effect 
of high frequency rTMS to DLPFC during long-lasting muscle pain. Finally, the 
thesis is completed in the fifth chapter with a brief conclusion and future 
perspectives. Suggestions of different methods to provoke, probe and modulate pain 
neuroplasticity are proposed and, the translation of these experimental findings to 
chronic musculoskeletal pain is highlighted.  
The primary content of this thesis is based on 3 original papers, which have been 
published in international peer-reviewed journals.    
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CHAPTER 1. INTRODUCTION 
Musculoskeletal pain poses one of the major health-related burdens on human 
population and it is the main cause of disability worldwide
1
. Despite several years of 
pain research, long-term management of MSK pain still remains inefficient
1
.  
One of the main problems in planning and developing long-term therapeutic 
strategies is that the pathophysiological mechanisms causing pain are not completely 
understood
2
. Although the recent development of imaging techniques, the 
association between pain and tissue abnormalities remains poor
3–9
, indicating that 
the pathoanatomical origin may not be sufficient to explain pain chronicity. 
Recently, a stronger relationship has been described between pain intensity and pain 
duration, and central sensitization
4,10
, impaired motor control
11,12
 and psychosocial 
factors
13–16
. Consequently, the role of the nervous system in chronic musculoskeletal 
pain have been highlighted
3,4,17
, leading to the introduction of the so-called 
“maladaptive pain neuroplasticity”. This pathophysiological mechanism is derived 
from the hypothesis that intense and prolonged nociceptive inputs provoke 
dysfunctional plastic changes of the nervous system 
2,17,18
.  
1.1. WHAT IS NEUROPLASTICITY? 
Neuroplasticity is the capacity of neurons to change in function, form and number 
19,20
. Neuroplasticity is the consequence of  i) events in the external environment 
able to activate receptors; ii) the activities of neurons that are spontaneously active; 
and iii) factors and substances in the local environment able to modulate the neural 
activity 
19
. In physiological conditions, adaptive neuroplasticity results in changes in 
the synaptic connection strength between neurons, and it is a fundamental 
mechanism for improving brain functioning. For instance, it represents a critical 
neural substrate for learning and memory 
19–21
.  
1.2. WHAT IS MALADAPTIVE PAIN NEUROPLASTICITY? 
Maladaptive neuroplasticity is the pathological side of neuroplasticity, and it is 
based on an imbalance synaptic function of the nervous system
17
. The results of 
maladaptive neuroplasticity is a loss of coordination and function of the nervous 
system, causing disability and reduction of quality of life
17
. In the recent years, 
maladaptive neuroplastic changes during the process of pain chronification have 
been described from the peripheral to the cortical levels (structural and functional 
changes)
17,22
. Therefore, it has been suggested that intense and prolonged 
nociceptive inputs from a pathological tissue may lead to dysfunctional neuroplastic 
changes
17,22
. Indeed, based on several neurophysiological and neuroimaging 
measurements, the dysfunctional activity of the nervous system, accompanied by 
structural remodeling, have been observed in patients affected by chronic 
musculoskeletal pain
17,22
.    
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However, the causality and the time-course between pain and maladaptive 
neuroplasticity is still unknown since no longitudinal studies, assessing the neural 
function before the pain becomes chronic and in different stages of the disease (i.e.,  
<6 weeks and >3 months), exist. Therefore, it is still not known how neuroplasticity 
is impaired during the transition from acute to persistent pain and when these 
neuroplastic changes appear.  
A simplistic approach, to reduce complexity between pain and neuroplasticity, is to 
apply experimental persistent pain models in healthy subjects. The main scientific 
advantage of using these models is to create causality and to provide information 
about the temporal profile of neuroplasticity during the transition from acute to 
persistent pain. Besides, since the researcher strictly controls the stimuli provoking 
pain, this approach offers the opportunity to experimentally investigate pain 
neuroplasticity, avoiding other confounding factors and co-morbidities connected to 
clinical pain conditions. 
1.3. HOW TO PROVOKE PAIN NEUROPLASTICITY? 
Temporary and reversible neuroplastic adaptations have been experimentally 
described in response to several different external stimuli, such as anesthetic 
blocks
23
, electrical stimulation
24
, immobilization
25,26
, repetitive transcranial magnetic 
stimulation
27
 and motor training
28–30
. Similarly to them, short-lasting painful 
stimulation induced experimentally in healthy subjects results in changes in neural 
excitability, due probably too extensive nociceptive inputs entering the nervous 
system
31,32
.  
Different methods can provoke experimental muscle pain
2,33
. Based on the time 
profile, the pain models can be divided based on short-lasting (few minutes) or long-
lasting (few days) pain models. In this project, repeated injections of intramuscular 
injection of nerve growth factor (NGF), a neurotrophic protein released 
physiologically during an inflammatory process
34
, and eccentric exercise-induced 
delayed onset muscle soreness (DOMS) have been used since both models can 
provoke prolonged muscle pain over several days. Indeed, a previous study has 
shown that multiple intramuscular injections of NGF are capable of inducing 
progressive muscle pain up to 21 days
35
. Importantly, NGF-induced muscle pain 
simulates the time-course (slow development of muscle pain) and processes 
involved in the transition to persistent musculoskeletal pain, such as hypersensitivity 
to mechanical pain and temporal summation of pressure, and thus provides a 
realistic model for investigating long-lasting muscle pain 
35–38
.  
In contrast, eccentric exercise-inducing DOMS provokes muscle pain up to 5-6 
days
39,40
, amd it can be applied only a single time because it produces training 
effects
41
. The mechanism underlying this kind of muscle pain is related to 
ultrastructural muscle damage caused by tissue overloading, and it results in the 
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release of several algesic substances, such as bradykinin, prostaglandins and NGF 
42,43
. 
1.4. HOW TO PROBE PAIN NEUROPLASTICITY? 
Several different neurophysiological and neuroimaging techniques have been used 
to probe pain neuroplasticity in healthy subjects such as functional magnetic 
resonance imaging (fMRI)
44
, magneto- (MEG) and electro- (EEG) 
encephalography
45–47
, and transcranial magnetic stimulation (TMS)
31,48
. Indeed, 
altered cortical excitability has been recorded not only during acute pain but also 
when pain vanished
49
, indicating that nociceptive inputs induce temporary and 
reversible neuroplastic changes. More specifically, evoking motor evoked potentials 
(MEPs), as produces by TMS, Le Pera et al.
31
 showed an inhibition of the primary 
motor cortex (M1) during 5-10 minutes of acute muscle pain and around 30 minutes 
after the pain disappeared
31,48
. Besides, Rossi et al.
45
 showed inhibition of early 
sensory evoked potentials (SEPs) induced by low-threshold afferents from the ulnar 
nerve after injecting levo-ascorbic solution into the first dorsal interosseous muscle. 
The inhibition of early SEPs lasted around 30 minutes after the pain disappeared
48
, 
confirmed similar temporary neuroplastic changes in the somatosensory cortical 
areas.  
Recently, neuroplastic changes have also been described after applying repeated 
injections of NGF into the extensor carpi radialis brevis (ECRB) muscle in healthy 
subjects
38
. In contrast with acute pain induced by hypertonic saline injection, 
injections of NGF induced altered motor cortex organization and impaired function 
characterized by expansion of motor cortex excitability, that is present few days 
after developing muscle pain
38
. Consequently, this experimental pain model 
provided, for the first time, the opportunity to investigate the neuroplastic 
adaptations across several days. 
1.5. HOW AND WHERE TO MODULATE PAIN 
NEUROPLASTICITY?  
Different type of non-invasive cortical stimulations have been proposed to 
therapeutically induce cortical neuroplasticity in neurological and psychiatric 
disorders
50,51
. For instance, TMS consists of electromagnetic pulses inducing 
electrical currents in the cortex via a coil placed on the head
51,52
. The application of 
repeated electromagnetic stimuli to a single scalp position is called “repetitive 
transcranial magnetic stimulation” (rTMS)
28
. These stimuli lead to temporary 
cerebral modulation through the modification of cortical excitability
28
, changes in 
blood flow to the stimulated area
53–56
, and release of several neurotransmitters such 
as dopamine, serotonin, opioids, gamma-aminobutyric acid  (GABA) and 
glutamate
57–60
. Additionally to the local action, TMS acts on distant structures via 
several brain connections
61–63
. For this reason, this technique has been proposed as a 
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possible intervention able to modulate maladaptive neuroplasticity in several 
neurological and psychiatric conditions
51
. 
In the context of experimental pain, several different areas of the brain have been 
shown to be active
44
. Pain-related brain activation has been shown in the primary 
sensory cortex, anterior cingulate cortex (ACC), insula, prefrontal, and motor 
regions
64
. In addition, the left dorsolateral prefrontal cortex (DLPFC) shows 
abnormal function in chronic pain populations
65,66
, and it is frequently activated in 
experimental pain studies.  
Based on evidence that left DLPFC morphology and function reflect chronic pain 
conditions, and it is linked to pain regulation, this cortical region has been suggested 
as a therapeutic target
67
. Indeed, several studies have also shown that 10 Hz rTMS to 
this area can temporary reduce acute or chronic pain
60,68–70
. 
1.6. AIMS AND GOALS OF THE PH.D PROJECT  
The three goals of this work were 1) to probe the clinical manifestations of long-
lasting muscle pain models; 2) to probe the nature and the temporal profile of 
cortical excitability adaptations in response to long-lasting muscle pain and 3) to 
investigate whether 5-daily sessions of rTMS over the left DPFC modulate the 
clinical manifestations and the cortical excitability adaptations induced by long-
lasting muscle pain.  
Three steps were necessary to achieve these goals: 
i) To provoke muscle pain applying three different long-lasting experimental pain 
models: 1) eccentric exercise-induced DOMS, 2) intramuscular injections of NGF-
induced muscle pain and 3) a combination between NGF-induced muscle pain and 
eccentric exercise-induced DOMS (Chapter 2).  
ii) To probe cortical excitability by motor evoked potential (corticomotor output) 
and sensory evoked potentials (sensory cortical integration of afferent inputs) during 
the three long-lasting muscle pain models (Chapter 3).  
iii) To modulate cortical excitability changes induced by long-lasting muscle pain 
(intramuscular injections of NGF) applying consecutive 5-daily sessions of 10 Hz 
left DLPFC rTMS (Chapter 4).  
Dissertation outline and Papers: 
Fig 1 summarizes the research approach used to provoke, probe and modulate pain 
neuroplasticity and the connections between the studies.  
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Fig. 1 Dissertation outline. 
Primary papers: 
Study I: Enrico De Martino, Laura Petrini, Siobhan Schabrun, Thomas Graven-
Nielsen Cortical somatosensory excitability is modulated in response to several days 
of muscle soreness. Journal of Pain, 2018.  
Study II: Enrico De Martino, Matteo Zandalasini, Siobhan Schabrun, Laura 
Petrini, Thomas Graven-Nielsen Experimental muscle hyperalgesia modulates 
sensorimotor cortical excitability, which is partially altered by unaccustomed 
exercise. PAIN, 2018.  
Study III: Enrico De Martino, David Seminowicz, Siobhan Schabrun, Laura 
Petrini, Thomas Graven-Nielsen Repetitive transcranial magnetic stimulation on left 
dorsolateral prefrontal cortex modulates the sensorimotor cortex function in the 
transition to sustained muscle pain. NeuroImage, 2018   
These papers will be referred to from hereon as named above (Study I, Study II and 
Study III).  
Secondary paper: 
Supplement Paper I: David Seminowicz, Enrico De Martino, Siobhan Schabrun, 
Thomas Graven-Nielsen. Left dorsolateral prefrontal cortex repetitive transcranial 
magnetic stimulation reduces the development of long-term muscle pain. PAIN, 
2018. 
This paper will be referred to from hereon as named above (Supplement Paper I). 
The effects of pain-induced neuroplasticity are addressed in the Study I and Study II 
(Chapter 2 and 3) while the modulatory effect of daily sessions of left DLPFC rTMS 
on the NGF pain model is addressed in the Study III and Supplement Paper I 
(Chapter 4).  
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CHAPTER 2. PROVOKING PAIN 
NEUROPLASTICITY 
To probe the clinical manifestations of long-lasting muscle pain, three different 
models have been used in this project: 1) eccentric exercise-induced DOMS (Study 
I); 2) intramuscular injections of NGF (Study II and Study III); 3) Combined 
intramuscular injections of NGF and eccentric exercise induced-DOMS (Study II).  
2.1. ECCENTRIC EXERCISE-INDUCED DOMS 
Eccentric exercise-induced DOMS is recognized as an effective endogenous 
technique for inducing musculotendinous hyperalgesia
41,71,72
 due to damage of the 
ultrastructural and cytoskeletal components of muscle fibers
40
. Muscle pain and 
hyperalgesia peak around 24–48 h after the exercise, followed by reduced range of 
movement and muscle strength in the affected muscle group
71
. However, when 
muscle pain is recovered, the second bout of exercise is not able to induce a similar 
muscle pain and muscle hyperalgesia, because of a training effect of the overload
41
. 
Importantly, resting pain is not a feature of this pain model, mimicking muscle 
hyperalgesia to mechanical pressure, muscle pain during contraction and stretching, 
attenuation of force parameters, and functional disability typical of musculoskeletal 
pain disorders.  
To induce DOMS in this project, repetitive eccentric contractions were performed 
from maximal wrist extension to maximal wrist flexion. Briefly, one bout consisted 
of five repetitions separated by 1-min rest period. The bout began with a load of 
around 90% of the maximal voluntary contraction (MVC) and was repeated until the 
subject was not able to control the contraction. Then, the weight was reduced in 
steps of around 10% MVC until a load of around 50% MVC in the final bout (Study 
I and Study II).  
To define the temporal profile of pain characteristics and cortical excitability 
adaptations in response to long-lasting muscle pain, the Study I comprised five 
identical long sessions on four different days (fig 2). In each session, data were 
collected in the following sequence: 1) Pain related questionnaires, 2) 
neurophysiological testing and 3) quantitative motor and sensory assessments. 
Additional information about the study design is reported in Study I. 
 
 
19 
 
Fig 2: Clinical and neurophysiological outcome measures were collected on Day-1, Baseline, Post, Day 2 
and Day 6 (Study I). 
2.2. NERVE GROWTH FACTOR-INDUCED MUSCLE PAIN 
Several studies have shown that inflammation can produce essential changes in the 
sensitivity of neurons from the nerve endings to the cortical neurons
17,73,74
. One of 
the main neurotrophic protein that is released during an inflammatory process and 
can influence neural function is NGF
34
. When NGF is experimentally injected into a 
muscle, increased sensitivity to mechanical pressure has been reported for several 
days
36,37
. Besides, multiple injections of NGF can induce muscle pain until 21 
days
35
, giving the opportunity to investigate the effect of muscle pain over 3 weeks. 
Finally, similar to exercise inducing DOMS, pain at rest is not a feature of this pain 
model, mimicking, therefore, the deep tissue hyperalgesia, functional disability and 
the pain location typical of mild/moderate lateral epicondylalgia (LE) until 21 days. 
In study II and III, 5µg/0.5 mL injections of NGF into the ECRB muscle were 
applied 2 or 3 times to provoke pain along the right forearm (ultrasound guided). 
To probe the temporal profile of cortical excitability adaptations in response to 
progressively developing muscle pain, Study II comprised three identical long 
sessions and a short session on four different days (Fig 3). As in Study I, the long 
session consisted of 1) Pain related questionnaires, 2) neurophysiological testing and 
3) quantitative motor and sensory assessments. The short session consisted on 1) 
pain related questionnaires, and 2) quantitative motor and sensory assessments. 
Besides, questionnaires were also sent by email on Day 6, 8, 10, 12, 14, 17 and 20. 
Additional information about the study design is reported in Study II. 
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Fig 3: clinical and neurophysiological outcome measures were collected on Day 0, Day 2, Day 4 and Day 
6 (study II). 
2.3. COMBINED NGF AND DOMS MODELS 
Repeated injections of NGF and eccentric exercise-induced DOMS were combined 
to achieve a long-lasting muscle pain (until 20 days), deep tissue hyperalgesia, 
attenuation of force parameters, functional disability and pain around the lateral 
epicondyle. Only a previous studies combined a single injection of NGF and DOMS 
to investigate the additive effects of these two pain models
75
. According to that 
study, the combination of the two models induced higher intensity of muscle pain 
and pain sensitivity to mechanical pressure compared with DOMS model
75
.  
To probe the temporal profile of cortical excitability adaptations in response to 
progressively developing muscle pain induced by NGF and eccentric exercise, a 
combined NGF and DOMS model was used using the same study design of Study II 
(Fig 4). 
 
Fig 4: Clinical and neurophysiological outcome measures were collected on Day 0, Day 2, Day 4 and 
Day 6 (Study II). Note: at Day 4 eccentric exercise-induced DOMS was applied before the NGF injection. 
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2.4. QUATIFING INTENSITY, FUNCTIONAL LIMITATION AND 
LOCATION OF MUSCLE PAIN 
Consistent with previous pain model studies (appendix B), different questionnaires 
were used to quantify the temporal profile of the clinical manifestations of long-
lasting muscle pain in Study I, II, III and Supplement Paper I.  
- A modified 7-point Likert scale was used to assess muscle pain 
intensity
37,71
.  
- Patient rated tennis elbow evaluation (PRTEE) was used to measure the 
functional disability
76
.  
- Body charts were used to quantify location and spatial distribution of 
perceived muscle pain
37,71
.  
The subjects were requested to complete the questionnaires at the beginning of each 
experimental session (Study I, II, III) or through email diaries (Study II, Supplement 
Paper I). Detailed information about the questionnaires is reported in Study I. 
2.5. PAIN INTENSITY TO MECHANICAL PRESSURE 
Mechanical pressure is one of the modalities used to assess pain sensitivity. 
Importantly, pressure pain threshold (PPT) has been extensively used to investigate 
pain sensitivity during DOMS and NGF pain models
37,38,41,71,72,77
, and the present 
work showed the excellent reliability of these measures (ICC = 0.84) (Appendix A). 
In the current work (Study I, II and III), PPTs was slowly increased until the subject 
detected the first sensation of pain and then pressed a button. To quantify the local 
and widespread effect of muscle pain, PPTs were recorded bilaterally at the extensor 
carpi radialis (ECR) muscle and tibialis anterior (TA) muscle. 
2.6. MAXIMAL WRIST EXTENSOR FORCE 
To quantify the effect of DOMS and NGF on maximal voluntary contractions 
(MVC), wrist extension force was collected using a force sensor (Fig 5)
71,78
. The 
present work showed the excellent reliability of these measures (ICC = 0.88) 
(Appendix A). To date, previous studies have shown that DOMS reduced the wrist 
maximal force
71,72,77
 while intramuscular injections of NGF have been reported 
inconsistent results
38,78
.   
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Fig 5: The subject performed three maximal contractions and the force transducer recorded 
the maximal wrist extension force (Study I, II and III).  
2.7. COMPARISON BETWEEN THREE MUSCLE PAIN MODELS 
Consistent with previous studies
39,41,71,72
, eccentric exercise-induced DOMS 
provoked moderate muscle pain (muscle pain: ~4) (Fig 6), and mild functional 
disability (disability: ~25) at Day 2 (Fig 7). At Day 6, muscle pain and functional 
disability were almost completely recovered (Study I). 
In a previous study
37
, a single injection of NGF into ECRB muscle provoked mild 
muscle pain up to 1 week after the injection (muscle pain: ~3 and disability: ~20). 
When two injections (48 h interval within the injections) were applied into ECRB 
muscle
38
, moderate muscle pain up to 2 weeks was described (muscle pain: ~4 and 
disability: ~25). Study II showed that the third injection of NGF into ECRB muscle 
was able to extend muscle pain until 3 weeks after the first injection (Fig 6). 
However, the intensity of muscle pain and the function disability were similar to 2 
injections of NGF (muscle pain: ~4 and disability: ~25) (Fig 7), indicating that an 
additional injection extended the duration of muscle pain but not pain intensity. In 
contrast, when eccentric exercise was applied in a NGF pain model (NGF+DOMS 
group), the intensity of muscle pain (muscle pain: ~5) and the functional disability 
(disability: ~35) increased compared with the NGF only (Study II). However, the 
duration of muscle pain and functional disability were not affected by the combined 
model (Fig 6 and Fig 7). 
The muscle pain area was localized along the radial site of the right elbow in all 
groups (Study I and Study II) (Fig 8). Combined NGF + DOMS models showed 
more extensive areas of muscle pain compared with the NGF group (Study II)  
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Fig. 6: Mean (± SEM, N = 12) Likert scores of muscle pain for DOMS, NGF and NGF+DOMS groups. 
Note: DOMS group performed eccentric exercise at Day 0. NGF group and NGF+DOMS group received 
3 NGF injections on Day 0, Day 2 and Day 4. NGF+DOMS group performed eccentric exercise on Day 
4. Significant differences in muscle pain between Groups and Days are illustrated by * (P < 0.05) 
(statistical analysis Study II). 
 
Fig. 7: Mean (± SEM, N = 12) patient-rated tennis elbow evaluation (PRTEE) for DOMS, NGF and 
NGF+DOMS groups. Significant differences in PRTEE questionnaire between Groups and Days are 
illustrated by * (P < 0.05) (statistical analysis Study II). 
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Fig. 8: Areas of muscle pain for DOMS, NGF and NGF+DOMS groups. Significant differences in body 
charts between Groups and Days are illustrated by * (P < 0.05) (statistical analysis Study II). 
Similar to with previous studies decreased sensitivity to mechanical pressure is 
commonly reported in response to muscle pain induced by eccentric exercise
41,71,72,77
 
and intramuscular injections of NGF
37,38
 (Fig 9). In the Study I, the peak of muscle 
hyperalgesia was two days post exercise, and it was completely recovered six days 
after the exercise. Repeated injections of NGF were able to maintain similar levels 
of muscle hyperalgesia in Day 2, Day 4 and Day 6. Interestingly, the combination of 
intramuscular injections of NGF and DOMS was not able to additionally increase 
muscle hyperalgesia, likely because of NGF-receptors saturation in the forearm 
muscle (study II).   
 
 
Fig. 9: Mean (± SEM, N = 12) normalized pressure pain threshold (% of Day 0) for DOMS, NGF and 
NGF+DOMS groups. A significant difference in pressure pain threshold compared with Day 0 and 
between Days is illustrated by * (P < 0.05) (Statistical analysis Study I and Study II). 
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The decrease of maximal force is commonly reported during DOMS, but 
controversial findings have been reported after injections of NGF. The Study I and 
the Study II (NGF + DOMS) confirmed that DOMS reduced the maximal force 
(~20% reduction compared with Day 0) while NGF induced a minimal reduction of 
maximal force (less than 5% of reduction compared with Day 0) (Fig 10). 
Considering that muscle pain and the area of pain are very similar between the two 
models (Likert scale: ~4), damage of muscle fibers may explain the difference 
between the two models.  
 
 
Fig. 10. Mean (± SEM, N = 12) normalized wrist extension maximal force (% of Day 0) for DOMS, 
NGF, and NGF+DOMS groups. A significant difference in maximal wrist extension force compared with 
Day 0 is illustrated by * (P < 0.05) (Statistical analysis Study I and Study II). 
In summary, the DOMS model and NGF model induced similar intensity of muscle 
pain, functional disability and muscle hyperalgesia, however, the reduction of 
maximal force is only evident in the DOMS model. Repeated injections of NGF can 
extend the duration of muscle pain and functional disability up to 20 days while 
DOMS induced muscle pain and functional disability until 6 days.  
The combination of 3 NGF intramuscular injections and eccentric exercise-induced 
DOMS allows provoking more intense muscle pain, larger muscle pain areas, and 
functional disability at day 6 as well as reduction of maximal force. However, the 
duration of muscle pain and muscle hyperalgesia were not affected by the combined 
model.   
2.8. MAIN FINDINGS ADDING TO THE CURRENT KNOWLEDGE 
 3 injections of NGF induced muscle pain until 20 days. 
 3 injections of NGF did not increase the peak intensity of muscle pain, area 
of muscle pain and muscle hyperalgesia compared with 2 NGF injections. 
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 3 injections of NGF combined with DOMS induced an increase of pain 
intensity, functional disability and area of muscle pain compared with only 
3 injections of NGF, but did not extend the pain duration and muscle 
hyperalgesia. 
 1, 2, or 3 injections on NGF did not reduce the maximal force. 
 Reduction of maximal force induced by DOMS on a pre-sensitized muscle 
was the same reduction as DOMS without pre-sensitization.  
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CHAPTER 3. PROBING CORTICAL 
PAIN NEUROPLASTICITY 
Following a transient stimulus, such as electric, visual, auditory or tactile, the 
nervous system generates a series of electrical potentials with latencies ranging from 
few milliseconds to hundreds of millisecond according to the type of nervous fibers. 
By placing recording electrodes over specific anatomical locations, these electrical 
potentials can be collected and processed
79
.  
In the current work, SEPs, provoked by electrical stimulation of the radial nerve, and 
MEPs, evoked by TMS to the ECRB, have been collected and analyzed to probe 
neuroplastic changes induced by muscle pain across several days. Classically, 
cortical neuroplasticity has been demonstrated in the somatosensory and motor 
cortical areas after a motor learning task
21,29,80,81
. For instance, applying TMS, 
Pascual-Leone et al. demostrated that the cortical motor map of the muscles 
involved in a motor task became progressively larger until explicit knowledge was 
learnt, illustrating a rapid functional plasticity of motor cortical areas
21
.  Similarly, 
several authors have described that the centro-parietal SEPs decreased and frontal 
SEPs increased following 20 minutes of repetitive typing
80,82,83
, indicating rapid 
functional plastic changes in the cortical areas related to sensorimotor integration of 
afferent inputs.  
In pain research, evoking MEPs, Le Pera et al.
31
 showed an inhibition of the M1 
during 5-10 minutes of acute muscle pain and around 30 minutes after the pain 
disappeared
31,48
. Similarly, Rossi et al.
32
 showed an inhibition of early SEPs after 
muscle pain into upper and lower limbs
32,45
. In addition, Schabrun et al., 
demonstrated that the inhibitory effect lasted for several minutes after the pain 
vanished
48
. In recent years several other authors showed neuroplastic effects induced 
by acute muscle pain in the corticomotor output and sensory cortical excitability 
(Appendix C shows a list of papers using MEPs and SEPs to probe cortical 
excitability changes induced by experimental pain; systematic review
49
).  
3.1. MOTOR EVOKED POTENTIALS 
To probe corticomotor output changes induced by long-lasting muscle pain, MEPs 
evoked by TMS to ECRB have been used (Study I, Study II and Study III). TMS 
generates a current in the cerebral cortex able to stimulate the axons of the neurons 
in M1
50
 (Fig 11). To record the motor response, surface recording electrodes were 
located in a bipolar configuration along the muscle fibres of the ECRB muscle with 
the reference placed on the olecranon
38
.  
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Fig. 11: The participants were seated with a swimming cap marked with a 1 × 1 cm grid. Recording 
electrodes were placed along the ECRB muscle and referred to the olecranon (not displayed in the image).  
Three neurophysiological measures have been collected in this progect: Rest Motor 
Threshold (rMT), MEPs and Motor Maps: 
1) rMT was the lowest intensity of the stimulator at which 5 out of 10 stimuli 
applied at the hot spot of the muscle at rest evoked a response with a peak-to peak 
amplitude higher than 50 μV
50
.  
2) MEPs were collected at 120% of rMT over the hot spot of ECRB muscle at rest to 
evaluate corticomotor excitability
50
.  
3) A motor map is defined as the territory where MEPs can be induced using a fixed 
stimulation intensity. In this project the TMS intensity was 120% of the individual’s 
rMT and 5 stimuli at each site of the grid were delivered in a pseudo-randomly 
order
38,84,85
 (Fig 12 and 13). 
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Fig 12: Illustrative example of 5 pulses delivered in the center of a motor map. 5 peak-to-peak MEPs 
were combined and displayed to check the absence of muscle activity before the TMS pulse (A), the MEP 
in the time window between 20 and 40 ms after the stimulation (red lines) (B). Trial-to-trial variability in 
peak-to-peak MEP amplitude was checked by probability plot (C) and histogram (D).     
 
Fig 13: Illustrative example of 5 pulses delivered in the border of a motor map. The peak-to-peak MEPs 
were combined and displayed to check the absence of muscle activity before the TMS pulse (A), the MEP 
in the time window between 20 and 40 ms after the stimulation (red lines) (B). Trial-to-trial variability in 
peak-to-peak MEP amplitude was checked by probability plot (C) and histogram (D). Note: the lower 
peak-to-peak amplitude, the longer latency and the high variability of the response on the border of the 
map compared to the center of a map (fig 12). Wasserman et al., 86 suggested that the periphery of the 
muscle representation, with its lower density of corticospinal neurons, may generate fewer descending 
impulses in response to a standardized stimulation and require a longer time to achieve the temporal 
summation necessary for activation of spinal motoneurons87.  
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The border of the motor map was considered when no MEPs were evoked in the 
grid site. The number of active map sites (map area) and map volume were 
calculated off-line by an in-house matlab code. Briefly, if the average peak-to-peak 
amplitude of the MEPs evoked at that site was higher than 50 μV, the site was 
considered “active” (Study I, II and III). The map volume was the mean of all active 
sites (Study I, II and III). The centre of gravity (CoG) was defined as the amplitude-
weighted centre of the map and was calculated by 
∑ 𝑉𝑖 ∙𝑋𝑖
∑ 𝑉𝑖
;  
∑ 𝑉𝑖 ∙𝑌𝑖
∑ 𝑉𝑖
; where Vi 
represents mean MEP amplitude at each site with the coordinates Xi (latitude of 
CoG), Yi (longitude of CoG) 
86
.  
Therefore, each motor map produced four outcomes: a map volume (sum of MEPs), 
a map area (number of active sites), longitude and latitude of centre of gravity 
referred to 0,0 (vertex) (Fig 14). More details about the methodology are reported in 
Study I. 
 
Fig 14: illustrative example of superior and lateral view of a 3D motor map of a subject. Note: 0,0 is 
referred to the vertex of the head (Cz). A motor map generally shows discrete amplitude peaks, or "hot 
spots", closely spaced (yellow and orange squares). These points represent low threshold areas where 
corticospinal neurons projecting to the particular muscle are most concentrated 86.   
It is important to highlight that the methodology selected for this project makes 
impossible to determine the exact level of the excitability changes along the motor 
pathway. In fact, the amplitude of the MEP reflects the motor cortex and spinal 
motoneuron excitability. Therefore, the interpretation of the changes described in 
Study I, II and III were limited by the unspecificity of the outcome.  
The present work confirmed the excellent reliability of rMT (ICC=0.94) and CoG 
latitude (ICC=0.86), the fair to good reliability of MEP in the hot spot (ICC=0.65), 
motor cortical volume (ICC=0.67), motor cortical area (ICC=0.71) and CoG 
longitude (ICC=0.44) (Appendix A). 
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3.2. CORTICOMOTOR NEUROPLASTICITY 
The two TMS components affected by long-lasting muscle pain were the map 
volume (sum of all MEPs amplitude) and the map area (number of active sites) 
(Study I and Study II, Fig 15).  
 
 
 
Fig 15. Mean (± SEM, N = 12) normalized volume motor map an area motor map (% of Day 0) for 
DOMS, NGF and NGF+DOMS groups. A significant difference in motor map volume and motor map 
area compared with Day 0 and Groups illustrated by * (P < 0.05) (Statistical analysis Study I and Study 
II). NOTE: Study I no recordings at Day 4. 
 
Study I showed that muscle pain induced by eccentric exercise provoked a reduction 
of both motor map volume and area. Based on previous studies showing changes at 
spinal and peripheral level
88
 but not at cortical level
89
, the attenuation of the motor 
map excitability has been interpreted as a peripheral and/or spinal inhibitory effect 
provoked by muscle damage induced by eccentric exercise (Study I). In contrast, 
two injections of NGF facilitated the motor map excitability (Day 4), as previously 
reported
38
. In addition, Study II showed that a third injection of NGF maintained the 
facilitation of motor map excitability at Day 6 (NGF group). However, when 
eccentric exercise was applied, inhibitory effect of the motor map excitability was 
detected (NGF+DOMS group).  
As explained by Schabrun et al.
38
, the increase of motor map excitability during 
muscle pain induced by NGF may be a sign of neuroplastic changes underpinning 
the search for a new movement strategy. Indeed, an increase of motor map 
excitability has been shown during motor learning, and when a new motor strategy 
was acquired, the motor map excitability reduced
21
. A similar pattern has been 
described in the first phases of prolonged muscle pain as a new motor strategy is 
sought
38
. In fact, several studies have demonstrated an increased movement 
variability and muscles activity of the low back during experimental muscle 
pain
12,38,90
 but decreased variability in patients with chronic low back pain
12,38,91
. 
Interestingly, the increase of motor map between Day 4 and Day 6 was very similar, 
suggesting that additional time may be needed before the motor map reduces.  
CORTICAL NEUROPLASTICITY PROVOKED BY MUSCLE PAIN AND NON-INVASIVE CORTICAL MODULATION OF 
PAIN-INDUCED NEUROPLASTICITY 
32 
In contrast, a reduction of the motor map excitability was found when DOMS was 
provoked in a pre-sensitized muscle, suggesting that the inhibitory spinal and/or 
peripheral effects of DOMS interfered with cortical facilitation induced by NGF.  
 
The results of Study I and Study II suggested that muscle pain induced by NGF and 
eccentric exercise-induced DOMS provoked different adaptations of the motor map 
excitability, probably driven by different cortical and spinal mechanisms. While 
DOMS induced a depression of the motor map excitability, NGF-induced muscle 
soreness induced an increase of the motor map excitability. 
 
3.3. SENSORY EVOKED POTENTIALS 
SEPs are the neural responses to sensory stimuli recorded using 
electroencephalography (EEG)
92
. A stimulator was used to deliver 2 blocks of 500 
electrical stimuli of 1 ms duration at a rate of 2 Hz. Stimulus intensity was set at 3 
times the perceptual threshold detected in each session. To specifically activate the 
superficial branch of the radial nerve
93
, the cathode was located on the right radial 
styloid process while the anode was placed two cm proximal. To check the correct 
location of the electrodes, participants were asked to indicate on their hand the area 
of the electrical sensation induced by the stimulation. If the participants did not point 
to the first and second finger, the anode electrode was relocated medially or 
laterally. This branch of the radial nerve has been selected in this project because the 
radial nerve innervates all wrist and fingers extensor muscles (structures targeted by 
the pain models).  
To probe the neuroplastic changes induced by muscle pain in the frontal and parietal 
sensory cortical areas, SEPs have been recorded using an EEG cap including 64 
recording electrodes (Study I, II and III). The recording electrodes active during the 
electrical stimulation were the F3, F1, Fc3, Fc1, C3, C1, Cp3, Cp1, P3 and P1 scalp 
sites and the electrical signals were referred to the electrical signal recorded on 
contralateral earlobe. This configuration was selected to optimize the resolution of 
the frontal and centro-parietal evoked potentials
94
. To minimize the displacement of 
the recording electrodes over different sessions, the EEG cap was mounted 
according to 10-5 system with Cz orientated to the vertex of the head
95
. The vertex 
of the head was defined as the interception between nasion-inion and the inter-aural 
lines. 
The electrical signal was sampled at 2400 Hz, amplified (50000x), band-pass 
filtered off-line at 5-500Hz, divided in epochs of 400 ms (time windows -100 ms 
before the electrical stimulation to 300 ms after) and all traces were visually 
inspected for artefacts. Any contaminated epochs were manually rejected while the 
artefact-free epochs were averaged (Fig 16) (EEGlab).  
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Fig 16: The electrical signal recorded, filtered off-line at 5-500Hz, divided in epochs based on the 
electrical stimulation and cleaned from artefacts (EEGlab). A and B show centro-parietal (Cp1) and 
frontal recording electrodes (F1) of a subject. All trials (epochs) are plotted in the time-domain 
(amplitude ±10µV) and averaged.   
 
 
The peaks P14, N18, P22, N30, P45 and N60 in the frontal leads and P14, N20, P25, 
N33, P45 and N60 in the parietal traces
96
 were automatically identified by an home-
made program running on MatLab (Fig. 17).Visual check confirmed the correct 
peaks and, finally, the pre-stimulation interval was used to normalise the peak 
amplitude.  
The amplitudes and latencies of each peak were imported in statistical software for 
the statistical comparisons.  
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Fig. 17: The traces were separately plotted and local peaks of each recording electrodes in the data vector 
were automatically found in specific time windows. Visual inspection confirmed the correct identification 
of the peaks. The pre-stimulation interval (between the red lines) was used to normalise the peak 
amplitude (subtracting the mean amplitude in the interval from -100 ms to -20 ms before the electrical 
stimulation)    
 
The present work confirmed the excellent reliability of P25 (ICC=0.84), P45 
(ICC=0.95) and N60 (ICC=0.77), and fair to good reliability of N20 (ICC=0.58) 
and N30 (ICC=0.63) (Appendix A). 
3.4. SOMATOSENSORY CORTICAL NEUROPLASTICITY 
Only the early SEPs (between 10-80 ms) collected over the contralateral centro-
parietal and frontal cortices have been extracted from the electrical signal. Previous 
studies have shown that these SEPs represent the earliest afferent inputs in the 
primary sensory (S1)
97
, supplementary motor area (SMA) and premotor cortex 
(PMC)
97–100
. In addition, these neural components have been shown affected by 
functional neuroplastic changes induced by motor learning
80,82,83
, immobilization
101
, 
deafferention
23,102
, pharmacological manipulations
103
,  repetitive transcranial 
magnetic stimulation
104,105
 and acute muscle pain
45,48,49
, making it reasonable to 
hypothesize that these neurophysiological measurements should also be affected by 
long-lasting muscle pain. 
The long-lasting muscle pain models used in this project are characterized by the 
absence of pain at rest, while injections of algesic substances, such as hypertonic 
saline, used in previous studies provoke acute muscle pain
45,48
. Because acute 
muscle pain is accompanied by a loss of position sense and reduction of stimulus 
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perception, the depression of centro-parietal SEPs has been previously discussed as 
an effect of cortical gating of afferent inputs caused by acute pain
32,45
. In contrast, 
the absence of pain at rest during the electrical stimulation in the present project 
could not produce any cortical gating, but the cortical excitability changes have been 
interpreted as a sign of neuroplasticity of cortical processing of somatosensory 
afferents.  
 
The two SEPs components affected in this project were: N30 and P45. Indeed, the 
combined results of Study I and II showed that muscle pain provoked by injections 
of NGF reduced the peak amplitude of N30 while DOMS did not show any N30 
effect (Fig 18). 
 
 
 
Fig 18. Mean (± SEM, N = 12) normalized N30 from F1 recording site (% of Day 0) for DOMS, NGF 
and NGF+DOMS groups. DOMS group performed eccentric exercise at Day 0. A significant difference 
in N30 peak amplitude in F1 recording site compared with Day 0 illustrated by * (P < 0.05) (Statistical 
analysis Study I and Study II). 
Evidence from human studies have demonstrated that sensory inputs reach PMC and 
SMA either after synapsing in S1
106
 or via parallel independent pathway from the 
thalamus
107,108
.  It is well know that the N30 SEPs reduced during execution, 
observation and imagination of a movement ipsilateral to nerve stimulation
81,109–111
. 
In contrast, the N30 SEPs increased during execution of repetitive movements 
contralateral to nerve stimulation
80,82,83,105,112,113
. Importantly, using intra-cortical 
recording electrodes in epileptic patients, the PMC and the SMA have been shown 
to be the main generators of N30 SEPs
114
. Moreover, the depression of the N30 SEP 
component has been demonstrated in different neurological diseases, such as 
Parkinson disease
115
. This SEP component has also been linked to dopamine 
function since single doses of L-Dopa and apomorphine in Parkinson’s patients 
normalized the N30 amplitude
116,117
. Finally, inhibitory or facilitatory rTMS 
paradigms delivered to PMC and SMA modify this frontal component
105
. Based on 
these evidences, it has been suggested that this cortical component represents the 
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functionality of a complex interhemispheric cortico/subcortical network linking 
basal ganglia, thalamus, supplementary and pre-motor cortices
105,118
. The results of 
Study II demonstrated that long-lasting muscle pain provoked by NGF was able to 
modify the N30 SEPs, probably interfering with some aspects of the motor planning 
or the motor execution.  
However, at 30 ms of latency a second SEP generator from centro-parietal areas 
overlaps the frontal N30 SEPs. This second generator produces both the frontal N25 
potential (not considered in this project) and the parietal P25 response
119
. 
Consequently, it is possible that in the NGF group the decrease of the frontal 
negative potential (probably N25) corresponds to the increase of the parietal P25 
response, likely caused by a shift of the tangential source generating both responses 
(N25/P25) (Study III). Consequently, the observed N30 SEP modifications may also 
represent a parietal phenomenon. 
The results of Study II suggest that excitability changes provoked by NGF-induced 
muscle pain were evidenced by the decrease amplitude of the N30 SEP. The 
decrease of this early-latency SEP component, in the absence of changes to other 
earlier and later components, indicates a likely frontal cortical site for pain 
plasticity, however a parietal phenomenon cannot be excluded.  
 
The results of Study I and Study II showed that muscle pain provoked by both 
injections of NGF and eccentric exercise induced similar increase of peak amplitude 
of P45 (Fig 19). 
 
 
Fig 19. Mean (± SEM, N = 12) normalized P45 from Cp1 recording site (% of Day 0) for DOMS, NGF 
and NGF+DOMS groups. A significant difference in P45 peak amplitude in Cp3 recording site compared 
with Day 0 illustrated by * (P < 0.05) (Statistical analysis Study I and Study II). 
Intracortical and scalp recording studies have demonstrated that the earliest evoked 
potentials after the electrical stimulation of a nerve have an S1 origin
97,120
.  Although 
still debated, P45 recorded by scalp electrodes may reflect S1 activity
120
. Besides, S1 
may be involved in the process of pain 
121
 and, particularly, in the sensory-
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discriminative aspect of pain
120,122,123
. For instance, based intracortical recording 
studies, laser-evoked stimulations have shown to activate area 1 of S1
124,125
. Finally, 
inhibitory or facilitatory rTMS paradigms delivered to S1 modified the tactile 
stimuli and pain threshold, indicating that S1, in particular area 1, may play a role in 
some aspect of pain perception. However, P45 amplitude is also affected by 
attention
126,127
, therefore it cannot be completely excluded that the P45 amplitude 
increase, described in Study I and Study II, can be explained by changes in the 
subject’s attention to the affected territory. 
 
Excitability changes provoked by NGF-induced muscle pain and DOMS were 
evidenced by the increase amplitude of the P45 SEP. The increase of this mid-
latency SEP component, in the absence of changes to earlier components, suggests a 
centro-parietal cortical site for pain plasticity. However, changes in attention to the 
affected territory cannot be excluded.   
 
3.5. MAIN FINDINGS ADDING TO THE CURRENT KNOWLEDGE  
 DOMS is followed by corticomotor inhibition of the ECRB muscle. 
 Muscle pain induced by 3 injections of NGF revealed similar increase of 
corticomotor excitability at Day 6 compared with 2 injections at Day 4. 
 Application of DOMS on a pre-sensitised muscle injected by NGF 
depressed the corticomotor excitability. 
 Muscle pain induced by eccentric exercise, two and three injections of NGF 
induced a similar increase of P45 SEPs. 
 Muscle pain induced by two and three injections of NGF induced the same 
decrease of the peak amplitude of N30 SEPs. 
 The application of DOMS on a pre-sensitized muscle did not alter the SEP.  
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CHAPTER 4. MODULATING PAIN 
NEUROPLASTICITY 
rTMS is based on the application of repetitive trains of TMS to target specific 
cortical areas
128,129
. When a train of stimuli is delivered in specific time profile, 
changes in cortical excitability can be provoked and they have been interpreted as a 
sign of neuroplasticity
28
. However, the nature and the duration of the neuroplasticity 
induced by rTMS dependents on the interaction between the stimulation frequency, 
intensity, train duration and number of applications
129,130
. Classically, low frequency 
rTMS protocols (lower than 1Hz) inhibit cortical excitability while high frequency 
rTMS protocols (higher than 5 Hz) facilitate cortical excitability
129,131–134
 (for 
detailed information on previous rTMS studies and cortical excitability based on 
MEPs and SEPs see Appendix D).  
Briefly, to induce cortical excitability changes that last longer than the stimulation 
period (between 30 minutes and 1 hour)
129
, high stimulus intensities are needed 
(around rMT), high numbers of stimuli (more than 500) and periods of several 
minutes (between 10 and 30 minutes) (Appendix D). One approach to extend the 
duration of cortical neuroplasticity is to apply multiple daily sessions of rTMS 
paradigm
135,136
. Based on animal models, multiple applications of rTMS enhance the 
lifetime of synaptic neuroplasticity
137
. Similar effect has been shown in healthy 
subjects, with daily rTMS sessions producing long-lasting neuroplastic changes, 
longer than the effects seen following a single application (around 1 hour)
135,138
. 
However, more importantly, clinical studies, investigating the therapeutic value of 
rTMS, use multiple stimulations over consecutive days in order to achieve long-
lasting therapeutic effects (few days)
135
. 
4.1. THE ROLE OF THE LEFT DLPFC IN COGNITION AND PAIN 
The dorsolateral prefrontal cortex (DLPFC) is a brain region implicated in emotion, 
cognition and behavior
67,139
. The left DLPFC is expanded in humans compared with 
other primates, indicating a role in complex cognitive processes
67,140
. Recently, the 
left DLPFC has been suggested to play an important role in pain suppression and 
detection (for a detailed review, see
67
). Based on the results of neuroimaging studies, 
nociceptive stimuli have shown a strong activity of the left DLPFC
141
 in healthy 
subjects and  chronic musculoskeletal pain conditions are commonly associated with 
decreased of left DLPFC gray matter and reduced function
65,142,143
, reflecting 
probably a hypo-metabolic state. In addition, pain-relief interventions can reverse 
this structural and functional abnormality
66
, confirming that pain interferes with this 
cortical function. Interestingly, 10 Hz left DLPFC rTMS has been applied as a 
therapeutic target in experimentally induced skin pain
60
 and post-surgical pain
68,69
, 
indicating that nociceptive and anti-nociceptive synaptic transmission can be 
modulated by 10 Hz rTMS stimulation to the left DLPFC. The mechanisms by 
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which 10 Hz left DLPFC rTMS can induce pain relief is not unclear
67
. A first 
possible mechanism may be the activation of the descending modulatory 
endogenous opioidergic system
144
. For instance, based on diffusion tensor imaging, 
a recent study showed the existence of an anatomical circuitry from the 
periaquaductal grey and the nucleus cuneiformis to the left DLPFC
145
. A second 
possible mechanism is that the analgesic effects derived from the left DLPFC rTMS 
occur through modulation of the cognitive function and mood state
67,146
. Indeed, 
10Hz-rTMS over the left DLPFC provokes secondary changes in the left 
parahippocampal gyrus, the right insula, the right cingulate gyrus, the ipsilateral 
subgenual anterior cingulate cortex and medial orbitofrontal cortex
57,59
. 
In summary, the activity of left DLPFC may modulate pain perception and pain 
suppression, and two possible mechanisms have been proposed: 1) the activation of 
the descending modulatory endogenous opioidergic 2) the modulation of the 
cognitive function and mood state. 
4.2. HOW TO TARGET THE LEFT DLPFC 
A technical challenge to perform rTMS to the DLPFC is the appropriate location of 
the coil over the scalp
147,148
. While the location of the M1 is based on a measurable 
response of the MEPs, the stimulation of the DLPFC does not elicit any 
neurophysiological response. For this reason, alternative approaches based on scalp 
measurements have been developed for locating the DLPFC
148
. One of the earliest 
and most widely used approach is the “5 cm rule”, where the motor hotspot for the 
first interosseous muscle is first identified applying TMS on the motor cortex, and 
then the coil is moved 5 cm forward to this site
149
. However, the “5 cm rule” fails to 
stimulate the DLPFC in 1/3 of the patients undergoing treatment
148,150
. Based on a 
MRI study
151
, indicating an discrepancy of around 2 cm between the site identified 
with the 5 cm rule, a modified “7 cm rule” have been adopted, although these 
approach likewise appears not very reliable as well
148,152
. Therefore, an alternative 
approach, based on the 10–20 EEG electrode placement system, has been 
developed
148
 to localize the left DLPFC.  
The algorithm, named as “BeamF3”, provides the localization of the left DLPFC 
based on 3 measurements: left tragus- right tragus distance, nasion-inion distance 
and head circumference 
147,148
.  The BeamF3 algorithm has been compared with the 
MRI-guided neuronavigation and provide a reasonable approximation for locating 
the left DLPFC in a majority of subjects
148
 (used in Study III and Supplemetary 
paper I).  
4.3. 10 HZ RTMS TO THE LEFT DLPFC 
The rTMS protocol used in Study III and Supplementary paper I consisted of 1 
session per day for 5 consecutive days (from Day 0 to Day 4) (Fig. 20). Each 
intervention consisted of 80 trains of 5 second pulses with a frequency of 10 Hz and 
an interval of 10 seconds between each train. The total amount of pulses was 4000 
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per session
60,68
 and the total number of stimulations for the entire treatment was 
20000. The stimulation intensity used was 110% of the rMT of the FDI muscle and 
the coil was located at the left DLPFC according to the BeamF3 algorithm
147,148
. 
The pain model selected to induce long-lasting muscle pain consisted of two 
injections of NGF at Day 0 and Day 2 since detailed clinical and neurophysiological 
manifestations of this model has been previously investigated
38
.    
 
Fig 20: After assessments at Day 0, Day 1, Day 2, Day 3, and Day 4 participants received active or sham 
10 Hz left DLPFC rTMS. Pain related questionnaire regarding muscle pain (Likert scale) was completed 
on Days 0 to 14, while functional disability (PRTEE) and pain distribution (body chart) were completed 
on Days 0, 3, 5, 9, and 14. At Day 0 and Day 5, neurophysiological testing (motor evoked potentials and 
sensory evoked potentials) and quantitative motor and sensory assessments (wrist extensor force and 
pressure pain thresholds) were assessed. At Day 3, quantitative motor and sensory assessments were also 
assessed. 
4.4. EFFECTS OF 10 HZ LEFT DLPFC RTMS ON LONG-LASTING 
MUSCLE PAIN 
Pain intensity is one of the strongest predictor of the transition from acute to chronic 
pain
153,154
, therefore, interventions able to decrease pain intensity during the first 
stages of development may have the clinical application to prevent chronic pain after 
injury and tissue damage (Supplement Paper I). The results of Study III and 
Supplement Paper I showed that five consecutive days of left DLPFC rTMS reduced 
pain intensity (Fig. 21 A), functional disability (Fig. 21 B), spatial distribution (Fig. 
21 C) and muscle hyperalgesia to mechanical pressure (Fig. 21 D) induced by two 
injections of NGF. Importantly, these changes outlasted to 3 days after the 
intervention period (Fig. 21 A) but the duration of muscle pain was not affected by 
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the treatment. Maximal wrist extension force was not affected by NGF and by the 
treatment (Fig. 21 E). 
 
 
 
A 
B 
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Fig 19. Mean (± SEM, N = 15) Likert scores of muscle pain (A), PRTEE scores (B), pain areas (C), 
muscle pain sensitivity to mechanical pressure (D) and maximal wrist extension force (E) following NGF 
injections on Day 0 and Day 2. Note: 10 Hz left DLPFC rTMS occurred on Days 0, 1, 2, 3, and 4. 
C 
D 
E 
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4.5. EFFECTS OF 10 HZ LEFT DLPFC RTMS ON 
CORTICOMOTOR EXCITABILITY 
A previous study has demonstrated that muscle pain provoked by two intramuscular 
injections of NGF induced an increase of motor cortical excitability at Day 4
38
. 
These results have been confirmed and expanded in Study II. In Study III, the sham 
group showed a facilitation of motor map excitability at Day 5. In opposite, when 10 
Hz left DLPFC rTMS was applied, the motor map volume decreased (Fig 22) while 
the map area did not expand. A first explanation of this reduction of the motor map 
excitability reported in Study III was that the multiple stimulations of left DLPFC 
during muscle pain induced a pain relief and, consequently, a modulatory effect on 
the motor map excitability. A second explanation was that the reduced motor map 
excitability was caused by the multiple acute pain sensations that the participants 
experienced during active rTMS (Study III). Indeed, the MEPs depression has been 
observed during and after acute muscle pain
49
. In this study, the procedural score of 
pain from the 1
st
 to the 5
th
 session in the active rTMS group were 5.8 ± 0.8, 4.3 ± 
0.7, 3.9 ± 0.6, 3.5 ± 0.6 and 2.9 ± 0.5, respectively (Supplement paper 1). 
 
Fig 22. Mean (± SEM, N = 15) normalized map volume and map area (% of Day 0) in both groups. NGF 
injections were performed on Day 0 and Day 2 and 10 Hz left DLPFC rTMS occurred on Days 0, 1, 2, 3, 
and 4. 
4.6. EFFECTS OF 10 HZ LEFT DLPFC RTMS ON 
SOMATOSENSORY CORTICAL EXCITABILITY 
In Study III, the sham group showed a decrease of the N30 SEP similar to the N30 
SEP changes described in Study II (Day 4 and Day 6) (Fig 23). In contrast to the 
sham group and the results of Study II, 10 Hz left DLPFC rTMS increased the N30 
SEP (Study III).  
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Fig 23. Mean (± SEM, N = 15) normalized N30 peak amplitude in F1 recording site (% of Day 0) in both 
groups. NGF injections were performed on Day 0 and Day 2 and 10 Hz left DLPFC rTMS occurred on 
Days 0, 1, 2, 3, and 4. 
Opposite to the N30 SEP, an increase of the P45 SEP was found in both groups (Fig 
24). When muscle pain was induced by NGF and eccentric exercise was used 
subsequently, increased P45 SEP was observed (Study I and Study II). Interestingly, 
left DLPFC rTMS did not modulate the P45 SEPs (Study III) although the DLPFC 
has modulatory reciprocal connections to the associative sensory cortex but not 
directly with S1
155
.  
 
Fig 24. Mean (± SEM, N = 15) normalized P45 peak amplitude in Cp3 recording site (% of Day 0) in 
both groups. NGF injections were performed on Day 0 and Day 2 and 10 Hz left DLPFC rTMS occurred 
on Days 0, 1, 2, 3, and 4. 
In summary, 5-daily sessions of 10 Hz left DLPFC rTMS reduced motor map 
excitability, normally increased by long-lasting muscle pain, and increased N30 
SEPs. No changes were found on the P45 SEPs. These results suggested that daily 
sessions of 10 Hz left DLPFC rTMS modulate the cortical excitability induced by 
muscle pain across several days, likely by the frontal-basal ganglia network.  
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4.7. MAIN FINDINGS ADDING TO THE CURRENT KNOWLEDGE 
 10 Hz left DLPFC rTMS reduced the peak pain intensity on muscle pain 
provoked by NGF.  
 The analgesic effect lasted at least three days after the end of the treatment. 
 10 Hz left DLPFC rTMS did not reduced the duration of muscle pain 
induced by NGF. 
 10 Hz left DLPFC rTMS modulated the effects provoked by NGF on the 
motor map excitability. 
 10 Hz left DLPFC rTMS modulated the effect induced by NGF on the 
frontal cortical excitability. 
 10 Hz left DLPFC rTMS did not modulate the effect provoked by NGF on 
the centro-parietal cortical excitability.   
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CHAPTER 5. CONCLUSION 
The three goals of this PhD project were: 1) to characterize the nature and temporal 
manifestations of three long-lasting pain models (Study I and Study II), 2) to probe 
the nature and temporal cortical excitability changes during long-lasting muscle pain 
(Study I and Study II); 3) to modulate pain neuroplasticity using daily sessions of 
left DLPFC rTMS (Study III). 
The results of this project showed that NGF and DOMS provoked similar pain 
intensity, moderate functional disability and reduction of pain sensitivity to 
mechanical pressure. The combination of NGF and DOMS are able to induce higher 
pain intensity but not to extend the duration of muscle pain compared with the only 
NGF or DOMS. Finally, only DOMS is able to reduced maximal force. 
Both repeated injections of NGF and eccentric exercise-induced DOMS produced 
several neuroplastic effects in the corticomotor excitability: While NGF facilitated 
the motor map excitability DOMS depressed it. Moreover, only injections of NGF 
altered the sensorimotor integration of sensory afferents in the frontal cortex while 
both NGF and DOMS modified the sensory processing in the centro-parietal cortex. 
Finally, daily sessions of left DLPFC rTMS induced analgesic effects and modulated 
pain neuroplasticity induced by NGF in motor and premotor cortices but not the 
centro-parietal cortex (Fig 25). 
 
 
 
 Fig 25. Dissertation outline with main findings. 
 
5.1. FUTURE PERSPECTIVE 
1) Improvement of pain models used to simulate the clinical sensorimotor features 
of musculoskeletal pain. For instance, combination of repeated intramuscular 
injections of NGF, eccentric exercise-induced DOMS and repeated intramuscular 
injections of hypertonic saline may be able to mimic several sensorimotor features 
of musculoskeletal pain, such as long-lasting muscle hyperalgesia (pain duration), 
force deficits and episodic acute exacerbation (high pain intensity) of muscle pain. 
However, experimental prolonged muscle pain models cannot replicate other 
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features as anxiety, negative mood, increased fatigue, fear of movement, and fear of 
re-injury typical of chronic pain
156
. It is important to note that all these missing 
features may play a crucial role in the development of maladaptive pain 
neuroplasticity. Consequently, the combination of these experimental pain models 
with “sleep deprivation” 
157
 and tasks provoking “stress-induced hyperalgesia” 
158,159
 
may also mimic some different neuropsychological features of chronic 
musculoskeletal pain and may help to investigate maladaptive pain neuroplasticity.      
2) Applying more specific neurophysiological techniques to evaluate cortical 
neuroplasticity may help to understand the mechanisms behind pain-induced 
neuroplasticity and, therefore, to tailor specific neuromodulatory interventions. For 
instance, intra-cortical inhibition and intra-cortical facilitation may help to 
investigate mechanisms such as GABAA, GABAB and glutamate-NMDA receptors. 
Both receptors have been described affected in experimental muscle pain
160
 and 
clinical musculoskeletal pain condition
161,162
. Moreover, oscillatory models in the 
frequency domain during muscle pain can suggest thalamo-cortical disinhibition 
based on alpha oscillations
163
. For instance, preliminary evidences have shown 
reduced alpha oscillations during experimental pain
163
 and clinical pain
164–166
, 
suggesting that altered thalamo-cortical activity may be associated with pathological 
pain.  
 
3) Applying different rTMS paradigms at different cortical levels. For instance, theta 
burst stimulation (TBS) has gained much interest in the last 10 years because of its 
efficacy and its short stimulation period
135
. In fact, the main advantage of TBS is the 
shorter duration of the stimulation (less than 3 minutes) and fewer numbers of pulses 
(600 or 1200 pulses) compared with the ‘classical’ 10Hz-rTMS (from 1500 to 4000 
pulses in 15-20min)
60,144,167,168
. Moreover, a stronger analgesic effect
169
, and more 
reproducible neuroplastic effects
170,171
 have been reported with TBS. Consequently, 
therapeutic potential of multiple daily sessions of TBS could become a valid 
therapeutic option to induce prolonged neuroplastic changes and analgesic effects. 
Finally, different cortical areas can be targeted by the intervention, such as M1, S1, 
the insula or the anterior cingulate cortex. For instance, M1 stimulations have shown 
significant long-term analgesic effect with repeated high frequency rTMS sessions 
in neuropathic and non-neuropathic pain patients
51,168
.  
 
5.2. FOCUS ON TRANSLATION 
In this project the main reason to induce long-lasting muscle pain in wrist extensors 
muscle was to mimic some clinical sensorimotor features seen in lateral 
epicondylalgia (LE). LE is a debilitating musculoskeletal condition characterized by 
pain in the area of the lateral humeral epicondyle. LE affects around 3% of the 
general population
172
, with peaks of 15% in workers at-risk industries
173
 or in 
athletes
174
 using repeated upper limb and hands movements. Besides to the clinical 
pain and disability characteristics, bilateral sensorimotor impairments have been 
shown in patients with LE. Based on cross-sectional studies, altered joint position 
sense
156,175
, reduced maximal grip and wrist extension force
162,175
, slower reaction 
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time and speed of movement
176
, local and widespread mechanical hyperalgesia
177,178
, 
bilateral cold hyperalgesia
179,180
 have been described in lateral epicondylalgia 
patients, suggesting that the nervous system may play a role in the chronicity of this 
disease.  
Based on that, recent studies have also investigated and shown that the excitability 
and organization of the cortical and subcortical areas were altered in patients 
affected by lateral epicondylalgia. For instance, evidence of spinal cord 
hyperexcitability
181
, motor cortex hyperexcitability
182
, less intra-cortical 
inhibition
162
, and less intra-cortical facilitation in the M1 contralateral to the affected 
ECRB muscle
162
 have been shown in chronic lateral epicondylalgia patients 
compared with healthy controls.  
Similar clinical and neurophysiological findings have been also described in other 
chronic musculoskeletal pain conditions such as back pain
161,183–186
, knee pain
187–189
, 
and shoulder pain
190
 and they have been also interpreted as signs of maladaptive 
pain neuroplasticity. 
Based on the interpretation of these results, interventions able to non-invasively 
modulate cortical neuroplasticity can be a reasonable tool for the future management 
of musculoskeletal pain conditions. More specifically, future clinical studies 
applying rTMS in the early stage of a musculoskeletal pain conditions are necessary 
to evaluate whether rTMS applied in the first stage of this disease may reduce pain 
chronicity.  
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Test-retest reliability of MEPs, SEPs, 
PPT over the right ECRB muscle and 
maximal wrist extensor force 
(unpublished data) 
Test-retest reliability of MEPs, SEPs, PPT over the right ECRB muscle and max 
wrist extension force was performed in 22 healthy volunteers. 12 volunteers 
participated in Study 1 (Fig 2: data collected at Day -1 and Day 0) and 10 volunteers 
participated in Study II and Study III (Day 0).    
Statistical analysis: 
Absolute and relative reliability were calculated to assess test-retest reliability of the 
following measurements 1) motor evoked potentials (rMT, MEPs, map volume, map 
area, CoG latitude and CoG longitude), 2) sensory evoked potentials (N20, P25 and 
P45 on Cp3 EEG recording site and N30 and N60 on F1 EEG recording site), 3) 
right ECRB PPT and 4) right max wrist extension force.  
The absolute reliability was calculated using 1) Inter-individual and intra-individual 
coefficient of variation (CV)
191
 and 2) Bland Almond analysis
192
. 
1. Inter-individual and intra-individual CV was calculated with the following 
formula:  
 Coefficient of variation intra-individual (CVintra= SDintra-
individual/meanintra-individual*100). Then, the average of the CV for each 
subject was calculated.  
 Coefficient inter-individual between two baseline sessions 
((CVinter = SDmean of difference/(meanbaseline1+meanbaseline2)/2) *100). 
2. Bland almond analysis was plotted to inspect the homoscedasticity and 
reported all raw data; bias was the difference between 2 baseline plots 
against individual mean of the two baselines. Upper and lower limits of 
agreement (LoA) were showed as ±1.96 standard deviation (SD) of 
difference between sessions; (Table 1 and Figure 1). 
The relative reliability was assessed using intra-class correlation coefficient 
(ICC)
193
. Absolute agreement and 95% confidence interval (IC) were fixed. ICC was 
calculated using a two way random model; single measurement (3,1) and average 
measurement (3,k) were reported
191
. ICC values above 0.75 were considered 
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‘excellent’ reliability, in the interval between 0.40–0.75 fair to good reliability and 
less than 0.40 poor reliability
194
. 
Results:  
The results for rMT, CoG latitude, PPT over the right ECRB muscle, max wrist 
extension force, N60 in F1 recording site, P45 and P25 in Cp3 recording site 
exhibited excellent reliability. MEP in the hot spot, motor cortical map, motor 
cortical area N30 in F1 recording site, N20 in Cp3 recording site and CoG longitude 
exhibited the fair to good reliability (Table 1).  
Measure 
Reliability 
                   Absolute reliability Relative  reliability 
 CV 
(%) 
intra  
CV  
(%) 
inter  
Bland almond 
analysis  
ICC (3, 1)        ICC (3, k) 
MEP  Bias (lower LoA/ 
upper LoA) 
(95% confidential interval) 
rMT 2.9 6.1 0.73 (-3.6/5.0) 0.94 (0.86/0.97) 0.97 (0.92/0.99) 
MEP 16.1 38.0 -42.03  
(-496.6/412.5) 
0.65 (0.33/0.84) 0.79 (0.5/0.913) 
Map area 7.8 23.4 -0.12 (-7.8/7.5 )  0.71 (0.41/0.87) 0.83 (0.58/0.93) 
Map 
Volume 
14.1 40.1 53.88  
(-3855.8/3963.5) 
0.67 (0.35/0.85) 0.80 (0.52/0.92) 
Latitude 
CoG 
2.5 6.1 0.01(-0.71/0.73) 0.86 (0.71/0.94) 0.93 (0.83/0.97) 
Longitude 
CoG 
16.2 40.3 0.12 (-1.2/0.92) 0.44 (0.05/0.72) 0.61 (0.1/0.84) 
SEP      
N20 (Cp3) 20.7 40.8 0.2 (-0.83/1.23) 0.58 (0.23/0.8) 0.73 (0.37-0.89) 
P25 (Cp3) 16.1 39.3 0.01 (-0.99/1) 0.84 (0.65/0.93) 0.91 (0.79/0.96) 
N30 (F1) 15.0 38.8 0.11(-1.31/1.53) 0.63 (0.31/0.83) 0.77 (0.47/0.90) 
P45 (Cp3) 12.5 21.6 0.04 (-0.9/0.82) 0.95 (0.89/0.98) 0.98 (0.94/0.99) 
N60 (F1) 18.4 37.4 0.09 (-0.91/1.09) 0.77 (0.54/0.86) 0.85 (0.70/0.93) 
Clinical       
Max wrist 
force 
4.67 15.81 -1.2 (-44.25/41.86) 0.88 (0.73/0.95) 0.93 (0.84/0.97) 
PPT Right 9.57 22.35 -0.09 (-96.76/96.59) 0.84 (0.65/0.93) 0.91 (0.79/0.96) 
69 
 
69 
Table 1 reports absolute reliability (intra and inter-subject CV, Bland Almond analysis) and relative 
reliability measures (ICC).  
Conclusion: 
Compared to previous test-retest studies (intra-individual and inter-individual 
variability), similar results have been found in MEPs, motor cortical volume
195,196
, 
frontal and centro-parietal SEPs
193,197
 and PPT
198,199
 evaluated in separate sessions. 
In addition to previous results, the present findings indicate that these 
neurophysiological and clinical outcomes are also reliable when combined. 
ECR 
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Appendix A. Overview of studies 
investigating the effects of DOMS and 
NGF models on the elbow 
A summary of studies provoking long-lasting muscle pain models in the wrist 
extensor muscles is showed in the table below. A range of terms (pain, 
musculoskeletal pain, persistent pain, delayed onset muscle soreness, nerve growth 
factor, experimental muscle pain, hyperalgesia, lateral epicondylalgia; tennis elbow, 
elbow pain), grouped by main search terms, were used in combinations to search the 
following databases: Pubmed, Scopus and Web of Science. 
The table aims at highlighting the temporal profile of the measurements, the 
outcomes used to describe the pain model and the main findings.  
 
Authors and 
Journal 
Paper Title Pain model and 
Temporal Profile 
Outcomes used to 
describe pain model 
Main findings 
Leger et al.,  
Medicine & 
science in 
sports & 
exercise (2001) 
Muscle 
function at 
the wrist after 
eccentric 
exercise  
DOMS model 
(eccentric 
exercise).  
5 sessions: Day 0 
(Pre), 24 h (Day 
1), 48 h (Day 2), 
96 h (Day 4), and 
240 h (Day 10). 
Muscle pain intensity 
(Likert scale),  
Pain area distribution 
(body chart),  
Maximal wrist 
extension force 
Eccentric exercise 
by wrist extensors 
induced muscle pain 
around lateral 
epicondyle of the 
homerous and 
reduced maximal 
force of the wrist 
extensor muscles.  
Slater et al.,  
Eur J Pain 
(2003) 
Experimental 
deep tissue 
pain in wrist 
extensors—a 
model of 
lateral 
epicondylalgi
a  
DOMS model 
(eccentric 
exercise).   
3 sessions: Day 0, 
Day 1 and Day 7 
Muscle pain intensity 
(Likert scale),  
Pain area distribution 
(body chart),  
Pressure pain 
thresholds (pressure 
algometer),  
Maximal wrist 
extension force 
Muscle pain, 
mechanical 
hyperalgesia pr 
pressure and force 
reduction support 
the use of DOMS as 
an experimental 
model simulating 
the clinical 
sensorimotor 
correlates of lateral 
epicondylalgia. 
Slater et al.,  
Manual 
therapy (2006) 
Effects of a 
manual 
therapy 
technique in 
experimental 
lateral 
DOMS model 
(eccentric 
exercise). 
Two groups: 
control vs 
Muscle pain intensity 
(Likert scale),  
Pain area distribution 
(body chart),  
Pressure pain 
No significant 
differences in pain 
intensity, pain 
distributions, 
mechanical 
hyperalgesia to 
71 
 
71 
epicondylalgi
a (DOMS 
model) 
“mobilization-
with-movement” 
intervention.  
3 sessions: Day 0, 
Day 1 and Day 7 
thresholds (pressure 
algometer),  
Maximal wrist 
extension force 
pressure or force 
attenuation.  
Fernández-
Carnero et al.,  
Medicine & 
science in 
sports & 
exercise (2009) 
Pressure Pain 
Sensitivity 
Mapping in 
Experimentall
y Induced 
Lateral 
Epicondylalgi
a  
DOMS group 
(eccentric 
exercise). 
3 sessions: Day 0 
(before and 
immediately 
after), and Day 1 
(24 h after 
eccentric exercise) 
Pressure pain 
thresholds (pressure 
algometer) were 
assessed over 12 
points forming a 3 x 4 
cm matrix  
The most sensitive 
localizations for 
PPT assessment 
corresponded to the 
muscle belly of the 
ECRB.  
Delfa de la 
Morena et al.,  
Journal of 
Strength and 
Conditioning 
Research 
(2013) 
Pressure pain 
mapping of 
the wrist 
extensors 
after repeated 
eccentric 
exercise at 
high intensity. 
DOMS group 
(eccentric 
exercise).   
First test round: 
3 sessions: Day 0 
(before and 
immediately 
after), and Day 1 
(24 h after 
eccentric exercise) 
Second test 
round performed 
7 days later: 3 
sessions: Day 0 
(before and 
immediately 
after), and Day 1 
(24 h after 
eccentric exercise) 
Pressure pain 
thresholds (pressure 
algometer) were 
assessed over 12 
points forming a 3 x 4 
cm matrix  
A lack of 
hyperalgesia 
underlined 
adaptation after the 
second test round of 
eccentric exercise 
performed 7 days 
after the initial test 
round.  
Bergin et .,  
Pain Medicine 
(2015) 
Movement 
Evoked Pain 
and 
Mechanical 
Hyperalgesia 
after 
Intramuscular 
Injection 
of Nerve 
Growth 
Factor: A 
Model of 
Sustained 
Elbow Pain 
NGF model (1 
injection): 
Four experimental 
sessions: Days 0, 
2, 4, and 10, and 
completed a daily 
diary of their 
elbow pain  from 
Day 0 to Day 10 
Muscle pain intensity 
(Likert scale),  
Pain area distribution 
(body chart),  
Pressure pain 
thresholds (pressure 
algometer),  
 
A single 
intramuscular 
injection of NGF 
induces sustained 
elbow pain that is 
lasting for up to one 
week. 
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Schabrun et 
al.,  
Cerebral 
cortex (2016) 
Motor Cortex 
Reorganizatio
n and 
Impaired 
Function in 
the Transition 
to Sustained 
Muscle Pain 
NGF model (2 
injections): 
Four experimental 
sessions: Days 0, 
2, 4, and 14. 
Muscle pain intensity 
(Likert scale),  
Pain area distribution 
(body chart),  
Pressure pain 
thresholds (pressure 
algometer),  
Grip force 
Two NGF injections 
resulted in a 
progressive increase 
in pain and 
disability up to 2 
weeks.  
Mista et a., 
 J Pain (2016) 
Effects of 
Prolonged 
and Acute 
Muscle Pain 
on the Force 
Control 
Strategy 
During 
Isometric 
Contractions 
NGF model (1 
injection): 
Three 
experimental 
sessions: Days 0, 
2, 4 
 
Maximal wrist 
extension force 
No impairement of 
the maximal force 
after injection of 
NGF.  
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Appendix B. Overview of studies 
probing experimental pain on the upper 
limb using MEPs and SEPs 
A summary of studies examining the cortical excitability in response to 
experimental muscle pain models is showed in the table below. A range of terms 
(pain; musculoskeletal pain, persistent pain, experimental pain, motor cortex; motor 
evoked potential, transcranial magnetic stimulation, evoked potential, sensory 
evoked potentials), grouped by main search terms, were used in combinations to 
search the following databases: Pubmed, Scopus and Web of Science. 
The table aims at highlighting the muscle pain models, the outcomes used to 
describe the cortical excitability and the main findings.  
Authors Paper title Muscle pain model  Cortical 
excitability 
Main findings 
Le Pera et al.,  
Clin 
Neurophysiology 
(2001) 
Inhibition of 
motor system 
excitability at 
cortical and 
spinal level by 
tonic muscle 
pain 
Injection of 
hypertonic saline into 
the right ADM 
(short-lasting pain 
model) 
MEPs  Tonic muscle 
pain inhibited 
the corticomotor 
excitability.  
Rossi et al.,  
Clinical 
Neurophysiology 
(2003) 
Early 
somatosensory 
processing 
during tonic 
muscle pain in 
humans: 
relation to loss 
of 
proprioception 
and motor 
‘defensive’ 
strategies  
Ascorbic acid 
injection in the right 
first dorsal 
interosseous muscle 
(short-lasting pain 
model)  
SEPs. Reduction of the 
post-central 
N20-P25-N33 
complex.  
Svensson et al.,  
European Journal 
of Pain (2003)  
Suppression of 
motor evoked 
potentials in a 
hand muscle 
following 
prolonged 
painful 
stimulation  
Hypertonic saline in 
the FDI muscle 
(short-lasting pain 
model) 
MEPs (stimulus 
response curves)  
Muscle pain is 
followed by a 
depression of 
MEPs. These 
changes are at 
least in part due 
to a depression 
of the 
excitability of 
the 
motoneurones 
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in the spinal 
cord.  
Del Santo et al.,  
Brain Research 
(2007) 
Corticospinal 
drive during 
painful 
voluntary 
contractions at 
constant force 
output  
Injection of ascorbic 
acid in the muscle 
belly of ADM and 
BIC (short-lasting 
pain model) 
MEP Acute pain 
during 
voluntary 
isometric 
contractions 
increased the 
MEP in both 
proximal and 
distal upper 
limb muscles 
(opposite effect 
to rest MEPs). 
Schabrun et al.,  
J Pain (2012) 
Muscle Pain 
Differentially 
Modulates 
Short Interval 
Intracortical 
Inhibition and 
Intracortical 
Facilitation in 
Primary Motor 
Cortex  
Hypertonic saline in 
the FDI muscle 
(short-lasting pain 
model) 
Short interval 
intracortical 
inhibition (SICI) 
and intracortical 
facilitation (ICF)  
SICI was 
increased 
following pain, 
but not during 
pain. ICF was 
decreased both 
during and after 
pain when 
compared with 
the pre-pain 
condition 
Schabrun et al.,  
Neuroscience 
(2013) 
Temporal 
association 
between 
changes in 
primary 
sensory cortex 
and 
corticomotor 
output during 
muscle pain. 
Hypertonic saline in 
the FDI muscle 
(short-lasting pain 
model) 
SEPs and MEPs  Pain reduces 
sensory 
processing 
(SEPs) before 
motor output is 
altered (MEPs). 
Schabrun et al.,  
Plos One (2015) 
New Insight 
into the Time-
Course of 
Motor and 
Sensory 
System 
Changes in 
Pain  
Hypertonic saline in 
the FDI muscle 
(short-lasting pain 
model) 
SEPs and MEPs S1 processing 
(SEPs) and 
corticomotor 
output (MEPs) 
are co-
modulated in 
association with 
muscle pain.  
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Schabrun et al.,  
Cerebral cortex 
(2016) 
Motor Cortex 
Reorganizatio
n and Impaired 
Function in the 
Transition to 
Sustained 
Muscle Pain  
NGF injection into 
ECRB muscles (long-
lasting pain model) 
MEPs, TMS 
mapping, SICI, 
ICF, 
interhemispheric 
inhibition 
Reorganization 
of M1 
characterized 
by: 1) increased 
map 
excitability, 2) 
reduced 
intracortical 
inhibition, 3) 
increased 
intracortical 
facilitation, 4) 
reduced 
interhemispheri
c inhibition 
from the 
“affected” to the 
“unaffected” 
hemisphere. 
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Appendix C. Overview of studies 
probing the neuroplastic effect of a 
single session rTMS using MEPs and 
SEPs 
A summary of studies examining the cortical excitability (MEPs and SEPs) in 
healthy subjects applying different rTMS parameters is showed in the table below. A 
range of terms (Sensory cortex; Motor cortex; cortical excitability, motor evoked 
potential, transcranial magnetic stimulation, evoked potential, sensory evoked 
potentials, repetitive transcranial magnetic stimulation, rapid-rate transcranial 
magnetic stimulation), grouped by main search terms, were used in combinations to 
search the following databases: Pubmed, Scopus and Web of Science. 
The table aims at highlighting the cortical area targeted by rTMS, frequency, 
intensity, number of pulses, duration of the intervention, cortical excitability after-
stimulation and duration of cortical excitability after the stimulation.  
Study Cortical 
area 
targeted 
by rTMS 
Frequency rTMS 
intensity 
No. of 
rTMS 
pulses 
Duration of 
intervention
s 
Cortical 
excitability 
after-
stimulation 
Duration 
of cortical 
excitability 
after-
effects 
Pascual-
Leone et al.,  
Brain (1994) 
M1  
1 Hz 100-
220% 
RMT 20 20 sec 
No MEP 
changes 
Not 
evaluated 
5-10 Hz 100-
220% 
RMT 20 2-4 sec 
↑ MEP 
amplitude  
~ 3 min 
20 Hz 100-
220% 
RMT 20 1 sec 
↑ MEP 
amplitude  
~ 3 min 
Chen et al.,  
Neurology 
(1997) 
M1  
0.9 Hz 115% 
RMT  
810 15 min ↓ MEP 
amplitude  
~ 3 min 
0.1 Hz 115% 
RMT  
360 1 h No MEP 
changes 
Not 
evaluated 
Berardelli et 
al.,  
Exp Brain Res 
(1998) 
M1  
5 Hz 120% 
RMT 
100 5 min ↑ MEP 
amplitude  
Not 
evaluated 
Rollkin et al.,  
Muscle Nerve 
(1999) 
left 
DLPFC 
5 Hz 90% 
RMT 
60 12 sec ↓ MEP 
amplitude  
~ 8 min 
Siebner et al.,  
Neurology 
(1999) 
M1  
1 Hz 90% 
RMT  
1800 30 min No changes on 
stimulus-
response curve 
Not 
evaluated 
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Wu et al., 
Neuroscience 
Letters (2000) 
M1 
5 Hz and 
15 Hz 
120% 
RMT 
30 6 sec, 2 sec ↑ MEP 
amplitude, 
↑ICF and ↓ 
ICI 
~ 1.5 min 
Muellbacher 
et al., Clin 
Neurophysiol
ogy (2000) 
M1 
1 Hz 115% 
RMT  
900 15 min ↓ stimulus-
response curve  
Not 
evaluated 
Maeda et al.,  
Clin 
Neurophysiol
ogy (2000) 
M1  
1 Hz 90% 
RMT  
240 4 min ↓ MEP 
amplitude  
24 hours 
10 Hz 90% 
RMT  
240 (3 
trains 
intreval 
72s) 
4 min No MEP 
changes 
24 hours 
20 Hz 90% 
RMT  
240 (6 
trains 
interval 
38s) 
4 min ↑ MEP 
amplitude  
24 hours 
Stefan et al. 
Brain (2000)  M1  
PAS 25 150% 
RMT  
90 pairs 
(ISI = 
25ms)  30 min 
↑ MEP 
amplitude  ~ 30 min 
Touge et al.  
Clin 
Neurophysiol
ogy (2001)  
M1  
1 Hz 95% 
RMT  
1500 25 min  ↓ MEP 
amplitude  
~ 30 min 
Gerschlager 
et al.,  
Neurology 
(2001) 
PMC 
1 Hz 90% 
AMT  
1500 15 min ↓ MEP 
amplitude  ~ 30 min 
left 
DLPFC 
1 Hz 90% 
AMT  
1500 15 min No MEP 
changes 
~ 60 min 
Enamoto et 
al., Clin 
Neurophysiol
ogy (2001) 
M1  
1 Hz 110% 
AMT 
200 200 s ↓ SEP 
amplitude 
(N20/P25 and 
P25/N33) 
~ 60 min 
S1  1 Hz 110% 
AMT 
200 200 s ↑ SEP 
amplitude 
(N20/P25 and 
P25/N33) 
~15 min 
Romero et 
al., Clin 
Neurophysiol
ogy (2002) 
M1  
1 Hz 90% 
RMT  
600 10 min  ↓ MEP 
amplitude  
~ 10 min 
Di Lazzaro et 
al.,  
Exp Brain Res 
(2002) 
M1 
5 Hz 120% 
RMT 
20 
4 s 
↑ MEP 
amplitude  
~ 2 min 
Fitzgerald et 
al., Clin 
neuroph 
(2002) 
M1  
1 Hz 85 and 
115% 
RMT 
900 15 min  both ↓ MEP 
amplitude  
Not 
evaluated 
Tsuji and 
Rothwell, 
Journal of 
M1  
PAS 20 105% 
RMT 
180 pairs 
(ISI = N20) 
30 min ↑ SEP 
amplitude 
(N20/P25, 
~15 min 
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Physiology  
(2002) 
P25/N33) 
Satow et al., 
neurology 
(2003) 
M1 
0.9 Hz  90% 
RMT 
900 15 min No changes 
SEP 
Not 
evaluated 
Grunhaus et 
al., 
International 
Journal of 
Neuropsycho
pharmacolog
y (2003) 
left 
DLPFC 
10 Hz 90% 
RMT 
1200 12 min ↑ MEP 
amplitude  
~30 min 
Gilio et al. 
(2003) 
J Physiol 
M1  
1 Hz 117% 
RMT 
900 15 min ↑ MEP 
amplitude in 
contralateral 
M1 
~ 20 min 
Wolters et al. 
(2003)  
J Physiol 
M1  
PAS 25 130% 
RMT  
90 pairs 
(ISI = 25 
ms) 30 min 
↑ MEP 
amplitude 
Not 
evaluated 
M1  
PAS 10 130% 
RMT  
90 pairs 
(ISI = 10 
ms) 30 min 
↓ MEP 
amplitude ~ 75 min 
Lyer et al., 
The Journal 
of 
Neuroscience 
(2003) 
M1 6 Hz-
primed 1 
Hz rTMS  
90% 
RMT 
and 
115% 
RMT 
No 
reported + 
600 
10 + 10 min 
↓ MEP 
amplitude 
~ 60 min 
Chouinard et 
al., J. 
Neurophysiol 
(2003) PMC 
1 Hz 90% 
rMT  
900 15 min 
↓ MEP 
amplitude 
Not 
evaluated 
Wolters et al. 
J Physiology 
(2005) 
S1  PAS N20 150% 
RMT 
180 pairs 
(ISI = N20) 
30 min ↑ SEP 
amplitude 
(N20/P25, 
P25/N33) 
~ 30 min 
S1  PAS N20-
20ms 
150% 
RMT 
180 pairs 
(ISI = N20-
20 ms) 
30 min ↓ SEP 
amplitude 
(N20/P25, 
P25/N33) 
~ 30 min 
Huang et al. 
Neuron 
(2005)  
M1  
cTBS 80% 
AMT  
300 20 s  ↓ MEP 
amplitude  
~ 20 min 
M1  
cTBS 80% 
AMT  
600 40 s  ↓ MEP 
amplitude  
~ 60 min 
M1  
iTBS 80% 
AMT  
600 190s ↑ MEP 
amplitude  
~ 20 min 
Olivieri et al., 
Neuroscience 
Letters (2005) 
Cereb. 
1 Hz 90% 
RMT 
600 10 min  ↑ MEP 
amplitude  
~ 30 min 
Lang et al. 
(2006)  
Neurology 
M1  
1 Hz 115% 
RMT  
900 15 min  ↓ MEP 
amplitude  
~ 20 min 
M1  
1 Hz 90% 
RMT  
900 15 min ↓ MEP 
amplitude 
~ 20 min 
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Urushihara et 
al.,  
NeuroImage 
(2006) 
PMC  1Hz 85% 
RMT  
250 250s 
↑ frontal N30 
SEP  
Not 
evaluated 
PMC  0.2 Hz 85% 
RMT  
250 250s No SEP 
changes 
Not 
evaluated 
Ishikawa et 
al., Clin 
Neurophys 
(2007) 
M1  
cTBS 80% 
AMT  
600 40 s  ↑ MEP 
amplitude  and 
↓ SEP 
amplitude 
(P25/N33, 
N33/P40) 
~ 40 min 
S1  cTBS 80% 
AMT  
600 40 s  no changes 
MEP 
amplitude and 
↓ SEP  
(P25/N33) 
~ 15 min 
Katayama et 
al.,  
Clin 
Neurophys 
(2007) 
M1  
iTBS 80% 
AMT  
600 190s No SEP 
changes 
~ 30 min 
S1  iTBS 80% 
AMT  
600 190s ↑  SEP 
amplitude 
(N20/P25) 
~ 30 min 
Fierro et al., 
Exp Brain 
Reseach 
(2007) 
Cereb
ellum 
1 Hz 90% 
RMT 
900 15 min ↑ MEP 
amplitude  
~ 20 min 
Hosono et al., 
Clin 
Neurophys 
(2008) 
PMC 1 Hz 85% 
RMT  
375 5 min ↑ frontal N30 
SEP  
~ 10 min 
Gentner et 
al., Cerebral 
Cortex (2008) 
M1  
cTBS 70% 
RMT 
600 40 s ↓ MEP 
amplitude 
~ 30 min 
Stefan et al., 
NeuroImage 
(2008) M1  
cTBS 80% 
AMT  
600 40 s ↓ MEP 
amplitude and 
↑ 
contralateral 
MEP  
~ 5 min 
Koch et al., 
Clin 
Neurophys 
(2008) 
Lat. 
cereb 
cTBS 80% 
AMT  
600 40 s  ↑ MEP 
amplitude  
~ 15 min 
Lat. 
cereb 
iTBS 80% 
AMT  
600 190s ↓ MEP 
amplitude  
~ 15 min 
Suppa et al., J 
Physiol 
(2008) 
M1  cTBS 80% 
AMT  
600 40 s ↓ MEP 
amplitude and 
↑ 
contralateral 
MEP  
~ 30 min 
Todd et al.,  
Exp Brain Res 
(2009) 
M1  
10 min 
2/6Hz + 
cTBS 
90% 
RMT 
and 70% 
AMT  
600 40 s (2 min 
interval) 
No MEP 
changes 
~ 30 min 
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M1  
cTBS + 
iTBS 
70% 
RMT + 
70% 
RMT 
1200 5 min  (2 min 
interval) 
↓ MEP 
amplitude 
~ 30 min 
Huang et al., 
Clin 
Neurophysiol 
(2009) 
PMC 
cTBS 80% 
AMT  
600 40 s ↓ MEP 
amplitude 
~ 60 min 
Premji et al., 
BMC 
Neurosci 
(2010) 
S1 
iTBS 80% 
AMT  
600 190s ↑ bilateral 
N20/P25 SEP 
~ 15 min 
Rothkegel et 
al.,  
Clinical 
Neurophysiol
ogy (2010) 
M1  
5 Hz (six 
blocks of 
200 pulses 
each with 
an 
intertrain 
interval of 
60 s) 
90% 
AMT  
1200 8 min ↓ MEP 
amplitude 
~ 15 min 
Fierro et al., 
Exp Brain 
Reseach 
(2010) 
left 
DLPFC 
5 Hz 90% 
RMT 
1800 8 min No MEP 
changes 
~ 30 min 
Gamboa et 
al., Exp Brain 
Res (2010) 
M1  
Prolonged 
ITBS 
(PiTBS) 
80% 
AMT  
1200 390s ↓ MEP 
amplitude 
~ 60 min 
M1  
Prolonged 
cTBS 
(PcTBS) 
80% 
AMT  
1200 80s ↑ MEP 
amplitude  
~ 60 min 
Katayama et 
al., Clin 
Neurophys  
(2010) 
S1  cTBS 80% 
AMT  
600 40 s  No SEP 
changes 
~ 30 min 
S1  iTBS 80% 
AMT  
600 190s ↑  SEP 
amplitude 
(N20/P25) 
~ 30 min 
Doeltgen et 
al., Clin 
Neurophysiol
ogy (2011) 
M1 cTBS 65% and 
70% 
RMT 
300 20s ↑ MEP 
amplitude 
(70% RMT); ↓ 
MEP 
amplitude 
(65% RMT) 
~ 30 min 
Doeltgen et 
al., Exp Brain 
Res (2011) 
M1 iTBS-
primed 
cTBS 
80% 
AMT  
600 190 s + 40 s 
(2 min 
interval) 
↓ MEP 
amplitude 
~ 30 min 
Premji et al., 
PlosOne 
(2011) 
S2  cTBS 80% 
AMT  
600 40 s  ↑ bilaterally 
MEP 
amplitude  
~ 60 min 
S2 iTBS 80% 
AMT  
600 190s ↑ 
controlateral 
MEP 
amplitude  
~ 60 min 
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Di Lazzaro et 
al., J 
Neurophysiol 
(2011)  
M1  
PAS 25 150% 
RMT  
90 
30 min 
↑ MEP 
amplitude  
~ 30 min 
M1  
PAS 10 130% 
RMT  
90 
30 min 
↓ MEP 
amplitude 
~ 30 min 
M1  
1 Hz 
110% 
RMT 900 30 min 
↓ MEP 
amplitude 
~ 30 min 
M1  
5 Hz 
90% 
RMT 900 15 min 
No MEP 
changes 
~ 30 min 
M1  
cTBS 
80% 
AMT 600 40 sec 
↓ MEP 
amplitude 
~ 30 min 
M1  
iTBS 
80% 
AMT 600 190 sec 
↑ MEP 
amplitude  
~ 30 min 
Doeltgen et 
al., European 
Journal of 
Neuroscience 
(2012) 
M1 
tDCS-
primed 
cTBS 
80% 
AMT 600 40 sec 
↓ MEP 
amplitude 
~ 60 min 
Torta et al., 
PlosOne 
(2013) 
M1  
cTBS 
80% 
RMT 600 40 sec 
No SEP 
changes 
Not 
evaluated 
S1  cTBS 
80% 
RMT 600 40 sec 
No SEP 
changes 
Not 
evaluated 
Legon et al., 
Brain 
stimulation 
(2013) 
SMA  cTBS 
80% 
AMT 600 40 sec 
↓ frontal N30 
SEP,  no 
changes MEP 
amplitude 
~ 30 min 
Jacobs et al., 
Brain 
stimulation 
(2014) 
S1  cTBS 
(30Hz) 
55% 
RMT 
600 40 sec 
↑ MEP 
amplitude  
~ 45 min 
M1  
cTBS 
(30Hz) 
55% 
RMT 600 40 sec 
↓ MEP 
amplitude 
~ 30 min 
Goldsworthy 
et al., Brain 
Stimulation 
(2014) 
M1  
cTBS 70% 
RMT 
and 80% 
AMT 
600 40 sec ↓ MEP 
amplitude 
~ 30 min 
Goldsworthy 
et al., 
Cerebral 
cortex (2014) 
M1  
spaced 
cTBS 
70% 
RMT 
1200 2*40 sec 
interval 10 
min 
↓ MEP 
amplitude 
~ 120 min 
Neva et al., 
Behavioural 
Brain 
Research 
(2014)  
PMC iTBS 
80% 
AMT  600 190 sec 
↑ MEP 
amplitude  
Not 
evaluated 
Brown et al., 
Behavioural 
Brain 
PMC cTBS 
80% 
AMT 600 40 sec 
↓ frontal N30 
SEP and N60 
SEP 
~ 30 min 
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Research 
(2015) 
Right 
DLPFC  
cTBS 
80% 
AMT 600 40 sec 
↑ frontal N30 
SEP and ↓ 
frontal N60, 
↑parietal P25 
and P40 
~ 30 min 
Opitz et al., 
Frontiers in 
Human 
Neuroscience 
(2015) 
left 
DLPFC 
cTBS 
80% 
AMT 600 40 sec 
↓ frontal N30 
SEP  and ↓P40 
~ 25 min 
Goldsworthy 
et al., Clin 
Neurophisiol 
(2016) 
M1  
cTBS 
70% 
RMT 600 40 sec 
I/O curves 
(peak ↓ 150%) 
~ 30 min 
M1  
iTBS 
70% 
RMT 600 190sec 
I/O curves 
(peak 
↑110%%) 
~ 30 min 
Tse et al., 
scientific 
reports 
(2018) M1 
spaced 
iTBS 
80% 
AMT  600 190 sec 
↑ MEP 
amplitude  
Not 
evaluated 
 
 
ISSN (online): 2246-1302
ISBN (online): 978-87-7210-326-6
